Publications: Dr Silvia Montoto

Hübel K, Bower M, Aurer I, Bastos-Oreiro M, Besson C, Brunnberg U, Cattaneo C, Collins S et al. ( 2024 ) . Human immunodeficiency virus-associated lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆ . Annals of Oncology vol. 35 , ( 10 ) 840 - 859 .

Hübel K, Bower M, Aurer I, Bastos‐Oreiro M, Besson C, Brunnberg U, Cattaneo C, Collins S et al. ( 2024 ) . Human immunodeficiency virus‐associated Lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up . HemaSphere vol. 8 , ( 9 )

Iqbal M, Kumar A, Dreger P, Chavez J, Sauter CS, Sureda AM, Bachanova V, Maziarz RT et al. ( 2024 ) . Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow Transplantation . Transplantation and Cellular Therapy vol. 30 , ( 9 ) 832 - 843 .

Berning P, Fekom M, Ngoya M, Goldstone AH, Dreger P, Montoto S, Finel H, Shumilov E et al. ( 2024 ) . Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years . Blood Cancer Journal vol. 14 , ( 1 )

Chabannon C, Ruggeri A, Montoto S, van Biezen A, van der Werf S, Markslag A, Sanchez-Ortega I, Camara RDL et al. ( 2024 ) . Celebrating the registration of 9.000 patients treated with CAR T cells in the EBMT registry: Collection of real-world data in the context of hematopoietic cellular therapies . Best Practice & Research Clinical Haematology vol. 37 , ( 2 )

Serroukh Y, Montoto S ( 2024 ) . Indolent Lymphoma . The EBMT Handbook , Springer Nature

Hübel K, Montoto S, Güven M, Duarte RF ( 2024 ) . Other B- and T-Aggressive Lymphomas and Lymphomas Associated with HIV . The EBMT Handbook , Springer Nature

Civallero M, Schroers‐Martin JG, Horwitz S, Manni M, Stepanishyna Y, Cabrera ME, Vose J, Spina M et al. ( 2024 ) . Long‐term outcome of peripheral T‐cell lymphomas: Ten‐year follow‐up of the International Prospective T‐cell Project . British Journal of Haematology vol. 205 , ( 1 ) 166 - 174 .

Paviglianiti A, Ngoya M, Peña M, Boumendil A, Gülbas Z, Ciceri F, Bonifazi F, Russo D et al. ( 2024 ) . Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor . Bone Marrow Transplantation vol. 59 , ( 5 ) 597 - 603 .

Di Ciaccio PR, Polizzotto MN, Cwynarski K, Gerrie AS, Burton C, Bower M, Kuruvilla J, Montoto S et al. ( 2024 ) . The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma . Blood vol. 143 , ( 2 ) 152 - 165 .

Montoto S ( 2024 ) . Chapter 6 Treatment of relapsed follicular lymphoma . Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal , Elsevier

Berning P, Boumendil A, Goldstone AH, Balari AMS, Dreger P, Montoto S, Ngoya M, Finel H et al. ( 2023 ) . Hematopoietic Stem Cell Transplantation for DLBCL: 55,000 Cases from EBMT As a Comparator for CAR T-Cells . Blood vol. 142 , ( Supplement 1 )

Civallero M, Advani R, Horwitz S, Manni M, Cabrera ME, Vose J, Spina M, Hits F et al. ( 2023 ) . Long term outcome of Peripheral T Cell Lymphomas: 10y follow‐up analysis of the International Prospective T Cell Project Network . Hematological Oncology vol. 41 , ( S2 ) 491 - 492 .

Bruch P-M, Dietrich S, Finel H, Boumendil A, Greinix H, Heinicke T, Bethge W, Beelen D et al. ( 2022 ) . Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters . Leukemia vol. 37 , ( 2 ) 465 - 472 .

Paviglianiti A, Mussetti A, Ngoya M, Boumendil A, Gulbas Z, Ciceri F, Bonifazi F, Russo D et al. ( 2022 ) . Graft-Versus-Host-Disease Prophylaxis with ATG or Ptcy in Patients with Lymphoproliferative Disorders Undergoing Reduced Intensity Conditioning Regimen 9/10 Mmud HCT . Blood vol. 140 , ( Supplement 1 ) 7645 - 7646 .

Baptista MJ, Tapia G, Muñoz‐Marmol A, Muncunill J, Garcia O, Montoto S, Gribben JG, Calaminici M et al. ( 2022 ) . Genetic and phenotypic characterisation of HIV‐associated aggressive B‐cell non‐Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications . Histopathology vol. 81 , ( 6 ) 826 - 840 .

Gagelmann N, Sureda A, Montoto S, Murray J, Bolaños N, Kenyon M, Beksac M, Schönland S et al. ( 2022 ) . Access to and affordability of CAR T-cell therapy in multiple myeloma: an EBMT position paper . The Lancet Haematology vol. 9 , ( 10 ) e786 - e795 .

Chiattone C, Civallero M, Fischer T, Miranda E, Manni M, Zing NPC, Pileri SA, Montoto S et al. ( 2022 ) . Characteristics and clinical outcomes of patients with ALK‐positive anaplastic large cell lymphoma: Report from the prospective international T‐cell lymphoma project . Hematological Oncology vol. 40 , ( 5 ) 953 - 961 .

Ellard R, Kenyon M, Hutt D, Aerts E, de Ruijter M, Chabannon C, Mohty M, Montoto S et al. ( 2022 ) . The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy: A Framework for Patient Care and Managing Common Toxicities . Clin Hematol Int vol. 4 , ( 3 ) 75 - 88 .

Bazarbachi A, Boumendil A, Finel H, Khvedelidze I, Romejko-Jarosinska J, Tanase A, Akhtar S, Ben Othman T et al. ( 2022 ) . Correction: The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years . Leukemia vol. 36 , ( 8 ) 2150 - 2150 .

Ellard R, Kenyon M, Hutt D, Aerts E, de Ruijter M, Chabannon C, Mohty M, Montoto S et al. ( 2022 ) . The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy: A Framework for Patient Care and Managing Common Toxicities . Clinical Hematology International vol. 4 , ( 3 ) 75 - 88 .

Waszczuk-Gajda A, Penack O, Sbianchi G, Koster L, Blaise D, Reményi P, Russell N, Ljungman P et al. ( 2022 ) . Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study . Journal of Clinical Medicine vol. 11 , ( 12 )

Gleeson M, Arias C, Cunningham D, Peckitt C, Du Y, Hujairi N, To YM, Chen H et al. ( 2022 ) . P1187: END OF TREATMENT 18F FDG‐PET/CT RESPONSE IS PROGNOSTIC FOR OVERALL AND PROGRESSION‐FREE SURVIVAL IN PERIPHERAL T‐CELL LYMPHOMA: RESULTS OF THE UK NCRI PHASE 2 RANDOMISED CHEMO‐T TRIAL PET/CT SUBSTUDY . HemaSphere vol. 6 , ( Suppl ) 1073 - 1074 .

Chiattone C, Civallero M, Fischer T, Miranda E, Manni M, Zing NPC, Pileri SA, Montoto S et al. ( 2022 ) . P1208: CHARACTERISTICS AND CLINICAL OUTCOMES OF PATIENTS WITH ALK‐POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA: REPORT FROM THE PROSPECTIVE INTERNATIONAL T‐CELL LYMPHOMA PROJECT . HemaSphere vol. 6 , ( Suppl ) 1094 - 1095 .

Bazarbachi A, Boumendil A, Finel H, Khvedelidze I, Romejko-Jarosinska J, Tanase A, Akhtar S, Ben Othman T et al. ( 2022 ) . The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years . Leukemia vol. 36 , ( 6 ) 1646 - 1653 .

Montoto S ( 2022 ) . Follicular lymphoma: life beyond the third line . The Lancet Haematology vol. 9 , ( 4 ) e241 - e242 .

Montoto S, Snowden JA, Chabannon C, Corbacioglu S, de la Camara R, Dolstra H, Greco R, Gusi A et al. ( 2022 ) . The first steps towards a diverse and inclusive EBMT: a position paper . Bone Marrow Transplantation vol. 57 , ( 3 ) 343 - 346 .

Hamadani M, Ngoya M, Sureda A, Bashir Q, Litovich CA, Finel H, Chen Y, Boumendil A et al. ( 2022 ) . Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics . Blood Advances vol. 6 , ( 3 ) 920 - 930 .

Perales M-A, Awan F, Boumendil A, Chen S, Bazarbachi A, Finel H, Glass B, Herrera AF et al. ( 2022 ) . Outcomes of allogeneic HCT in patients with Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis . BONE MARROW TRANSPLANTATION . vol. 57 , 11 - 12 .

Paviglianiti A, Mussetti A, Ngoya M, Boumendil A, Fegueux N, Bonifazi F, Gulbas Z, Ciceri F et al. ( 2022 ) . a comparison between atg and pt-cy graft-versus-host-disease prophylaxis in patients with lymphoma undergoing reduced intensity conditioning regimen HSCT from 1 antigen mmud . BONE MARROW TRANSPLANTATION . vol. 57 , 224 - 225 .

Caldwell L, Bapat A, Drumright L, Lambourne J, Jimenez-England F, Aries J, Eccersley L, Hallam S et al. ( 2021 ) . Cessation of ciprofloxacin prophylaxis in haemato-oncology patients . Clin Infect Dis

Gutiérrez‐García G, Martínez C, Boumendil A, Finel H, Malladi R, Afanasyev B, Tsoulkani A, Wilson KMO et al. ( 2021 ) . Long‐term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high‐risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party‐EBMT . British Journal of Haematology vol. 196 , ( 4 ) 1018 - 1030 .

Sellner L, Schetelig J, Koster L, Choi G, Blaise D, Beelen D, Schianca FC, Passweg J et al. ( 2021 ) . Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey . Bone Marrow Transplantation vol. 56 , ( 12 ) 3108 - 3108 .

Alonso-Álvarez S, Manni M, Montoto S, Sarkozy C, Morschhauser F, Wondergem MJ, Guarini A, Magnano L et al. ( 2021 ) . Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma . European Journal of Cancer vol. 157 , 132 - 139 .

Alderuccio JP, Olszewski AJ, Evens AM, Collins GP, Danilov AV, Bower M, Jagadeesh D, Zhu C et al. ( 2021 ) . HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis . Blood Advances vol. 5 , ( 14 ) 2852 - 2862 .

Greinix HT, Eikema D-J, Koster L, Penack O, Yakoub-Agha I, Montoto S, Chabannon C, Styczynski J et al. ( 2021 ) . Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study . Haematologica vol. 107 , ( 5 ) 1054 - 1063 .

Dreger P, Ngoya M, Litovich C, Finel H, Herrera AF, Sauter C, Kharfan‐Dabaja M, Sureda A et al. ( 2021 ) . ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR PERIPHERAL T‐CELL LYMPHOMA: COMPARABLE OUTCOMES OF HAPLO‐IDENTICAL VS. MATCHED DONORS. A CIBMTR & EBMT ANALYSIS . Hematological Oncology vol. 39 , ( S2 )

Conconi A, Vannata B, Janikova A, Ramirez A, Bodoni CL, Nowakowski G, Mian M, Ferreri AJM et al. ( 2021 ) . PRIMARY EXTRANODAL FOLLICULAR LYMPHOMA IN A LARGE RETROSPECTIVE SURVEY OF THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG31) . Hematological Oncology vol. 39 , ( S2 )

Eyre TA, Caillard S, Finel H, Boumendil A, Kothari J, Zimmermann H, Trappe RU, De Wilde V et al. ( 2021 ) . Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMT . Bone Marrow Transplantation vol. 56 , ( 9 ) 2118 - 2124 .

Advani RH, Skrypets T, Civallero M, Spinner MA, Manni M, Kim WS, Shustov AR, Horwitz SM et al. ( 2021 ) . Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project . Blood vol. 138 , ( 3 ) 213 - 220 .

Shouval R, Fein JA, Labopin M, Cho C, Bazarbachi A, Baron F, Bug G, Ciceri F et al. ( 2021 ) . Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry . The Lancet Haematology vol. 8 , ( 3 ) e205 - e215 .

Olszewski AJ, Jakobsen LH, Collins GP, Cwynarski K, Bachanova V, Blum KA, Boughan KM, Bower M et al. ( 2021 ) . Burkitt Lymphoma International Prognostic Index . Journal of Clinical Oncology vol. 39 , ( 10 ) 1129 - 1138 .

Pettengell R, Uddin R, Boumendil A, Johnson R, Metzner B, Martín A, Romejko-Jarosinska J, Bence-Bruckler I et al. ( 2021 ) . Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial . Bone Marrow Transplantation vol. 56 , ( 6 ) 1413 - 1421 .

Domingo-Domenech E, Duarte RF, Boumedil A, Onida F, Gabriel I, Finel H, Arcese W, Browne P et al. ( 2021 ) . Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation . Bone Marrow Transplantation vol. 56 , ( 6 ) 1391 - 1401 .

Zhang X-Y, Zhu C, Bower M, Santarsieri A, Martinez-Calle N, Kassam S, Phillips E, Montoto S et al. ( 2021 ) . HIV status does not impact on the outcome of patients with Burkitt lymphoma: a UK analysis . BRITISH JOURNAL OF HAEMATOLOGY . vol. 193 , 48 - 49 .

Penack O, Peczynski C, Mohty M, Yakoub-Agha I, Styczynski J, Montoto S, Duarte RF, Kröger N et al. ( 2020 ) . How much has allogeneic stem cell transplant–related mortality improved since the 1980s? A retrospective analysis from the EBMT . Blood Advances vol. 4 , ( 24 ) 6283 - 6290 .

Bazarbachi A, Boumendil A, Finel H, Khvedelidze I, Romejko-Jarosinska J, Tanase AD, Akhtar S, Othman TB et al. ( 2020 ) . Evolution of Outcome over Time for Relapsed Hodgkin Lymphoma after Autologous Stem Cell Transplant: Improved Survival for Early Relapse in Recent Years . Blood . vol. 136 , 9 - 10 .

Alderuccio JP, Olszewski AJ, Evens AM, Collins GP, Danilov A, Bower M, Jagadeesh D, Zhu C et al. ( 2020 ) . Prognostication, Survival and Treatment-Related Outcomes in HIV-Associated Burkitt Lymphoma (HIV-BL): A US and UK Collaborative Analysis . Blood . vol. 136 , 49 - 50 .

Di Ciaccio PR, Polizzotto MN, Cwynarski K, Burton C, Jiamsakul A, Bower M, Kuruvilla J, Montoto S et al. ( 2020 ) . Survival Outcomes for Plasmablastic Lymphoma: An International, Multicentre Study By the Australasian Lymphoma Alliance . Blood vol. 136 , ( Supplement 1 ) 1 - 2 .

Olszewski AJ, Jakobsen LH, Collins GP, Cwynarski K, Bachanova V, Blum KA, Boughan KM, Bower M et al. ( 2020 ) . The Burkitt Lymphoma International Prognostic Index (BL-IPI) . Blood . vol. 136 , 46 - 49 .

Cwynarski K, Khwaja J, Montoto S ( 2020 ) . ‘CARMEN’: is less, more? Lessons from trials in human immunodeficiency virus‐Burkitt lymphoma (HIV‐BL) . British Journal of Haematology vol. 192 , ( 1 ) 13 - 14 .

Bento L, Boumendil A, Finel H, Khvedelidze I, Blaise D, Fegueux N, Castagna L, Forcade E et al. ( 2020 ) . Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party—EBMT . Bone Marrow Transplantation vol. 56 , ( 3 ) 655 - 663 .

Skrypets T, Civallero M, Manni M, Pileri S, Weisenburger DD, Ko YH, Inghirami G, Bargetzi M et al. ( 2020 ) . TCL-233: Angioimmunoblastic T-Cell Lymphoma: Report on 282 Cases from the Prospective International T-Cell Lymphoma Project . Clinical Lymphoma Myeloma & Leukemia vol. 20 , s253 - s254 .

Re A, Cattaneo C, Montoto S ( 2020 ) . Treatment management of haematological malignancies in people living with HIV . The Lancet Haematology vol. 7 , ( 9 ) e679 - e689 .

Martínez C, Boumendil A, Romejko-Jarosinska J, Anagnostopoulos A, Faber E, Poiré X, Yakoub-Agha I, Akhtar S et al. ( 2020 ) . Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMT . Leukemia & Lymphoma vol. 61 , ( 12 ) 2915 - 2922 .

McNamara C, Montoto S, Eyre TA, Ardeshna K, Burton C, Illidge T, Linton K, Rule S et al. ( 2020 ) . The investigation and management of follicular lymphoma . British Journal of Haematology vol. 191 , ( 3 ) 363 - 381 .

Ljungman P, Mikulska M, de la Camara R, Basak GW, Chabannon C, Corbacioglu S, Duarte R, Dolstra H et al. ( 2020 ) . Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy . Bone Marrow Transplantation vol. 56 , ( 3 ) 755 - 755 .

McMillan AK, Phillips EH, Kirkwood AA, Barrans S, Burton C, Rule S, Patmore R, Pettengell R et al. ( 2020 ) . Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial . Annals of Oncology vol. 31 , ( 9 ) 1251 - 1259 .

Sellner L, Schetelig J, Koster L, Choi G, Blaise D, Beelen D, Schianca FC, Passweg J et al. ( 2020 ) . Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey . Bone Marrow Transplantation vol. 55 , ( 12 ) 2335 - 2338 .

Aries JA, Davies JK, Auer RL, Hallam SL, Montoto S, Smith M, Sevillano B, Foggo V et al. ( 2020 ) . Clinical Outcome of Coronavirus Disease 2019 in Haemato-oncology Patients . British Journal of Haematology

Sureda A, Genadieva Stavrik S, Boumendil A, Finel H, Khvedelidze I, Dietricht S, Dreger P, Hermine O et al. ( 2020 ) . Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMT . Bone Marrow Transplantation vol. 55 , ( 11 ) 2170 - 2179 .

Ljungman P, Mikulska M, de la Camara R, Basak GW, Chabannon C, Corbacioglu S, Duarte R, Dolstra H et al. ( 2020 ) . The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy . Bone Marrow Transplantation vol. 55 , ( 11 ) 2071 - 2076 .

Phillips EH, Burton C, Kirkwood AA, Barrans S, Lawrie A, Rule S, Patmore R, Pettengell R et al. ( 2020 ) . Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial . eJHaem vol. 1 , ( 1 ) 133 - 141 .

Okosun J, Montoto S ( 2020 ) . Cellular Therapy in Follicular Lymphoma Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, and Chimeric Antigen Receptor T-cell Therapy . Hematology/Oncology Clinics of North America vol. 34 , ( 4 ) 701 - 714 .

Fox CP, Civallero M, Ko Y-H, Manni M, Skrypets T, Pileri S, Kim SJ, Cabrera ME et al. ( 2020 ) . Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project . The Lancet Haematology vol. 7 , ( 4 ) e284 - e294 .

Passweg JR, Baldomero H, Chabannon C, Basak GW, Corbacioglu S, Duarte R, Dolstra H, Lankester AC et al. ( 2020 ) . The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus . Bone Marrow Transplantation vol. 55 , ( 8 ) 1604 - 1613 .

Fatobene G, Rocha V, St Martin A, Hamadani M, Robinson S, Bashey A, Boumendil A, Brunstein C et al. ( 2020 ) . Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR . Journal of Clinical Oncology vol. 38 , ( 14 ) 1518 - 1526 .

Dreger P, Fenske TS, Montoto S, Pasquini MC, Sureda A, Hamadani M, Research ESFBAMTATCFIBAMT ( 2020 ) . Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation? . Transplantation and Cellular Therapy vol. 26 , ( 4 ) e77 - e85 .

Duarte RF, Martinez-Munoz ME, Labopin M, Badoglio M, van Biezen A, Nguyen S, Diez JL, Passweg J et al. ( 2020 ) . Allogeneic Transplantation in Patients with HIV-infection: An Updated Pair-Matched Cohort Study by the European Society for Blood and Marrow Transplantation . BONE MARROW TRANSPLANTATION . vol. 55 , 22 - 23 .

Skrypets T, Civallero M, Manni M, Pileri S, Weisenburger DD, Ko YH, Inghirami G, Bargetzi M et al. ( 2020 ) . Angioimmunoblastic T-Cell Lymphoma: Report on 282 Cases from the Prospective International T-Cell Lymphoma Project . CLINICAL LYMPHOMA MYELOMA & LEUKEMIA . vol. 20 , S253 - S254 .

Chavda N, Robinson S, Boumendil A, Khvedelidze I, Finel H, Akhtar S, Rauf MS, Durakovic N et al. ( 2020 ) . Brentuximab Vedotin for Relapse After Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma. A Study of the LWP-EBMT . BONE MARROW TRANSPLANTATION . vol. 55 , 116 - 117 .

Foss FM, Horwitz SM, Civallero M, Bellei M, Marcheselli L, Kim WS, Cabrera ME, Dlouhy I et al. ( 2019 ) . Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas . American Journal of Hematology vol. 95 , ( 2 ) 151 - 155 .

Snowden JA, Saccardi R, Orchard K, Ljungman P, Duarte RF, Labopin M, McGrath E, Brook N et al. ( 2019 ) . Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) . Bone Marrow Transplantation vol. 55 , ( 4 ) 838 - 839 .

Lupo-Stanghellini MT, Peczynski C, Greinix HT, Polge E, Mohty M, Yakoub-Agha I, Montoto S, Kröger N et al. ( 2019 ) . From Ex-Vivo T-Cell Depletion to Post-Transplant Cyclophosphamide: Improved GvHD-Free & Relapse-Free Survival but Comparable Chronic GvHD Incidence in Haploidentical Transplantation. A 15 Years EBMT Registry Analysis on Behalf of the TCWP-EBMT . Blood . vol. 134 ,

Burney C, Robinson S, Boumendil A, Finel H, Khvedelidze I, Hunter H, Poire X, Lioure B et al. ( 2019 ) . Ibrutinib for Relapsed Mantle Cell Lymphoma after Standard First Line Therapy and ASCT Is Efficacious but Does Not Overcome the Impact of POD24 - a Retrospective Study from the LWP-EBMT . Blood . vol. 134 ,

Chavda ND, Robinson S, Boumendil A, Khvedelidze I, Finel H, Akhtar S, Rauf MS, Durakovic N et al. ( 2019 ) . Outcome of Patients with Hodgkin Lymphoma Treated with Brentuximab Vedotin for Relapse after Autologous Stem Cell Transplant: A Retrospective Analysis of the LWP-EBMT . Blood vol. 134 , ( Supplement_1 )

Shouval R, Fein JA, Labopin M, Bazarbachi A, Baron F, Bug G, Ciceri F, Corbacioglu S et al. ( 2019 ) . The Disease-Risk Stratification Scheme (DRSS), a Contemporary Risk-Stratification System for Allogeneic Stem Cell Transplantation . Blood . vol. 134 ,

Michallet M, Dreger P, Sobh M, Koster L, Hoek J, Boumendil A, Scheid C, Fox CP et al. ( 2019 ) . Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia . Bone Marrow Transplantation vol. 55 , ( 5 ) 884 - 890 .

Domingo-Domènech E, Boumendil A, Climent F, Socié G, Kroschinsky F, Finel H, Vandenbergue E, Nemet D et al. ( 2019 ) . Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation . Bone Marrow Transplantation vol. 55 , ( 3 ) 633 - 640 .

Domingo-Domènech E, Boumendil A, Climent F, Sengeloev H, Wahlin B, Wattad W, Arat M, Finel H et al. ( 2019 ) . Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT . Bone Marrow Transplantation vol. 55 , ( 4 ) 796 - 803 .

Snowden JA, Saccardi R, Orchard K, Ljungman P, Duarte RF, Labopin M, McGrath E, Brook N et al. ( 2019 ) . Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) . Bone Marrow Transplantation vol. 55 , ( 4 ) 681 - 694 .

Sureda A, Chabannon C, Masszi T, Pohlreich D, Scheid C, Thieblemont C, Wahlin BE, Sakellari I et al. ( 2019 ) . Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor . Bone Marrow Transplantation vol. 55 , ( 3 ) 613 - 622 .

González-Barca E, Boumendil A, Blaise D, Trněný M, Masszi T, Finel H, Michieli MG, Bittenbring JT et al. ( 2019 ) . Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT) . Bone Marrow Transplantation vol. 55 , ( 2 ) 393 - 399 .

Bazarbachi A, Boumendil A, Finel H, Castagna L, Dominietto A, Blaise D, Diez‐Martin JL, Tischer J et al. ( 2019 ) . Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma – a LWP‐EBMT study . British Journal of Haematology vol. 188 , ( 5 ) 745 - 756 .

Shouval R, Fein JA, Labopin M, Kröger N, Duarte RF, Bader P, Chabannon C, Kuball J et al. ( 2019 ) . Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis . The Lancet Haematology vol. 6 , ( 11 ) e573 - e584 .

Styczyński J, Tridello G, Koster L, Iacobelli S, van Biezen A, van der Werf S, Mikulska M, Gil L et al. ( 2019 ) . Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors . Bone Marrow Transplantation vol. 55 , ( 1 ) 126 - 136 .

Montoto S ( 2019 ) . Biosimilar drugs: how safe are they? . Leukemia & Lymphoma vol. 60 , ( 14 ) 3343 - 3344 .

Styczynski J, Tridello G, Gil L, Ljungman P, Mikulska M, Ward KN, Cordonnier C, de la Camara R et al. ( 2019 ) . Prognostic impact of EBV serostatus in patients with lymphomas or chronic malignancies undergoing allogeneic HCT . Bone Marrow Transplantation vol. 54 , ( 12 ) 2060 - 2071 .

Bento L, Boumendil A, Fine H, Khvedelidze I, Blaise D, Fegueux N, Castagna L, Forcade E et al. ( 2019 ) . S1622 TANDEM AUTOLOGOUS‐REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION IN HIGH‐RISK RELAPSED HODGKIN LYMPHOMA: A RETROSPECTIVE STUDY OF THE LWP‐EBMT . HemaSphere vol. 3 , ( S1 ) 749 - 750 .

Robinson S, Boumendil A, Finel H, Khvedelidze I, Kanfer E, Peggs K, Fuesrt S, Ram R et al. ( 2019 ) . DONOR LYMPHOCYTE INFUSIONS INDUCE DURABLE RESPONSES IN PATIENTS WITH FOLLICULAR, MANTLE AND T CELL LYMPHOMAS RELAPSING AFTER AN ALLOSCT. AN EBMT‐LWP STUDY . Hematological Oncology vol. 37 , ( S2 ) 316 - 317 .

Bazarbachi A, Boumendil A, Finel H, Castagna L, Dominietto A, Blaise D, Diez‐Martin J, Tischer J et al. ( 2019 ) . HOW TO SELECT DONOR, STEM CELL SOURCE, AND CONDITIONING REGIMEN FOR HAPLOIDENTICAL TRANSPLANTS WITH POST‐TRANSPLANT CYCLOPHOSPHAMIDE FOR LYMPHOMA: A REPORT OF THE EBMT LWP . Hematological Oncology vol. 37 , ( S2 ) 299 - 300 .

Burney CN, Robinson S, Boumendil A, Finel H, Khvedelidze I, Hunter H, Poire X, Lioure B et al. ( 2019 ) . THE EFFICACY OF IBRUTINIB IN PATIENTS WITH RELAPSED MANTLE CELL LYMPHOMA AFTER FIRST LINE INTENSIVE CHEMO‐IMMUNOTHERAPY AND ASCT – A RETROSPECTIVE STUDY FROM THE LWP‐EBMT . Hematological Oncology vol. 37 , ( S2 ) 243 - 244 .

Ruutu T, van der Werf S, van Biezen A, Backman JT, Peczynski C, Kröger N, Mohty M, Nagler A et al. ( 2019 ) . Use of busulfan in conditioning for allogeneic hematopoietic stem cell transplantation in adults: a survey by the Transplant Complications Working Party of the EBMT . Bone Marrow Transplantation vol. 54 , ( 12 ) 2013 - 2019 .

Dietrich S, Dreger P, Hermine O, Kyriakou C, Montoto S, Robinson S, Schmitz N, Schouten HC et al. ( 2019 ) . Haploidentical stem cell transplantation for patients with lymphoma: a position statement from the Lymphoma Working Party-European Society for Blood and Marrow Transplantation . Bone Marrow Transplantation vol. 55 , ( 2 ) 317 - 324 .

Kanate AS, Kumar A, Dreger P, Dreyling M, Le Gouill S, Corradini P, Bredeson C, Fenske TS et al. ( 2019 ) . Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation . JAMA Oncology vol. 5 , ( 5 ) 715 - 722 .

Schmidt-Hieber M, Tridello G, Ljungman P, Mikulska M, Knelange N, Blaise D, Socié G, Volin L et al. ( 2019 ) . The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT . Annals of Hematology vol. 98 , ( 7 ) 1755 - 1763 .

Duarte RF, Labopin M, Bader P, Basak GW, Bonini C, Chabannon C, Corbacioglu S, Dreger P et al. ( 2019 ) . Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019 . Bone Marrow Transplantation vol. 54 , ( 10 ) 1525 - 1552 .

Araf S, Wang J, Korfi K, Pangault C, Kotsiou E, Rio-Machin A, Rahim T, Heward J et al. ( 2019 ) . Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma . Leukemia vol. 33 , ( 6 ) 1540 - 1540 .

Hübel K, Re A, Boumendil A, Finel H, Hentrich M, Robinson S, Wyen C, Michieli M et al. ( 2019 ) . Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party . Bone Marrow Transplantation vol. 54 , ( 10 ) 1625 - 1631 .

Passweg JR, Baldomero H, Basak GW, Chabannon C, Corbacioglu S, Duarte R, Kuball J, Lankester A et al. ( 2019 ) . The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies . Bone Marrow Transplantation vol. 54 , ( 10 ) 1575 - 1585 .

Dreger P, Sureda A, Ahn KW, Eapen M, Litovich C, Finel H, Boumendil A, Gopal A et al. ( 2019 ) . PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL . Blood Advances vol. 3 , ( 3 ) 360 - 369 .

Montoto S ( 2019 ) . Localized FL: how long in response to be cured? . Blood vol. 133 , ( 3 ) 187 - 188 .

Penack O, Peczynski C, van der Werf S, Mohty M, Yakoub-Agha I, Montoto S, Finke J, Ganser A et al. ( 2019 ) . Association of serum ferritin levels before start of conditioning with mortality after alloSCT - a prospective, non-interventional study of the EBMT transplant complication working party . BONE MARROW TRANSPLANTATION . vol. 54 , 238 - 239 .

Penack O, Peczynski C, van der Werf S, Mohty M, Yakoub-Agha I, Montoto S, Finke J, Ganser A et al. ( 2019 ) . Association of uric acid levels before start of conditioning with mortality after alloSCT - a prospective, non-interventional study of the EBMT transplant complication working party . BONE MARROW TRANSPLANTATION . vol. 54 , 296 - 297 .

Lapierre B, Boumendil A, Creveuil C, Garciaz S, Peyrade F, Finel H, Khvedelidze I, Malak S et al. ( 2019 ) . Bendamustine-based versus BEAM conditioning regimen. A matched controlled study in diffuse large B-cell lymphoma from LYSA and LWP-EBMT . BONE MARROW TRANSPLANTATION . vol. 54 , 58 - 59 .

Dietrich S, Finel H, Lu J-J, Boumendil A, Sengeloev H, Socie G, Labussiere-wallet H, Maury S et al. ( 2019 ) . Myeloablative conditioning may contribute to disease control after stem cell transplantation in blastic plasmacytoid dentric cell neoplasia . BONE MARROW TRANSPLANTATION . vol. 54 , 108 - 109 .

Bramanti S, Boumendil A, Finel H, Khvedelidze I, Afanasyev B, Schmitz N, Blaise D, Ciceri F et al. ( 2019 ) . Post-transplant cyclophosphamide-based GVHD prophylaxis compared to standard prophylaxis in patients with lymphoma receiving HLA identical transplantation: A retrospective study from the LWP of EBMT . BONE MARROW TRANSPLANTATION . vol. 54 , 107 - 108 .

Bento L, Boumendil A, Finel H, Khvedelidze I, Blaise D, Fegueux N, Castagna L, Milpied N et al. ( 2019 ) . Tandem autologous-reduced intensity allogeneic stem cell transplantation in relapsed hodgkin lymphoma: A retrospective study of the LWP-EBMT . BONE MARROW TRANSPLANTATION . vol. 54 , 106 - 107 .

Shouval R, Fein JA, Labopin M, Duarte RF, Corbacioglu S, Bader P, Chabannon C, Kuball J et al. ( 2019 ) . Young HLA-matched unrelated donors are comparable to matched sibling donors in elderly patients receiving reduced-intensity conditioning: an analysis on behalf of the EBMT scientific council . BONE MARROW TRANSPLANTATION . vol. 54 , 602 - 603 .

Hübel K, Montoto S ( 2018 ) . Other T- and B-Aggressive Lymphomas and Lymphomas Associated with HIV . The EBMT Handbook , Springer Nature

Robinson S, Boumendil A, Finel H, Khvedelidze I, Kanfer E, Peggs K, Furst S, Ram R et al. ( 2018 ) . Donor Lymphocyte Infusions for the Treatment of Relapsed Non-Hodgkin Lymphoma Following Allogeneic Stem Cell Transplantation: A LWP-EBMT Study . Blood . vol. 132 ,

Robinson S, Boumendil A, Khvedelidze I, Finel H, Peggs K, Malladi RK, Potter V, Tsoulkani A et al. ( 2018 ) . Efficacy and Toxicity of Donor Lymphocyte Infusions in the Management of Mixed Donor-Recipient Chimerism Following Allogeneic Stem Cell Transplantation for Lymphoid Malignancies:- a Study of the LWP-EBMT . Blood vol. 132 , ( Supplement 1 )

Greinix HT, Eikema D-J, Koster L, Penack O, Yakoub-Agha I, Montoto S, Chabannon C, Styczynski J et al. ( 2018 ) . Incidence of Acute Graft-Versus-Host Disease and Survival after Allogeneic Hematopoietic Cell Transplantation over Time: A Study from the Transplant Complications and Chronic Malignancies Working Party of the EBMT . Blood . vol. 132 ,

Bazarbachi A, Boumendil A, Finel H, Castagna L, Dominietto A, Blaise D, Diez-Martin JL, Tischer J et al. ( 2018 ) . Influence of Donor Type, Stem Cell Source and Conditioning Regimen on Transplant Outcomes after Haploidentical Transplant with Post Transplant Cyclophosphamide for Lymphoma: A Report of the EBMT Lymphoma Working Party . Blood . vol. 132 ,

Alonso S, Manni M, Sarkozy C, Wondergem M, Guarini A, Magnano L, Alcoceba M, Chamuleau MED et al. ( 2018 ) . Risk of Histological Transformation in Patients with Primary Refractory Follicular Lymphoma . Blood . vol. 132 ,

Martinez C, Boumendil A, Romejko-Jarosinska J, Anagnostopoulos A, Faber E, Poire X, Yakoub-Agha I, Akhtar S et al. ( 2018 ) . Second Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma after a Previous Autograft: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation . Blood . vol. 132 ,

Wolf S, Goiriz R, Dhairyawan R, Paige D, Rizvi H, Haroon A, Montoto S ( 2018 ) . Brentuximab vedotin in multifocal cutaneous anaplastic large cell lymphoma in a patient with human immunodeficiency virus following Hodgkin lymphoma . Clinical and Experimental Dermatology vol. 44 , ( 5 ) 562 - 564 .

Bazarbachi A, Boumendil A, Finel H, Mohty M, Castagna L, Blaise D, Peggs KS, Afanasyev B et al. ( 2019 ) . Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party . Cancer . vol. 125 , 90 - 98 .

Baptista MJ, Tapia G, Morgades M, Muncunill J, Muñoz-Marmol A-M, Montoto S, Gribben JG, Calaminici M et al. ( 2018 ) . Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma . Leukemia & Lymphoma vol. 60 , ( 4 ) 1087 - 1091 .

Kyriakou C, Boumendil A, Finel H, Schmitz NN, Andersen NS, Blaise D, Chevallier P, Browne P et al. ( 2018 ) . The Impact of Advanced Patient Age on Mortality after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: A Retrospective Study by the European Society for Blood and Marrow Transplantation Lymphoma Working Party . Transplantation and Cellular Therapy vol. 25 , ( 1 ) 86 - 93 .

Paviglianiti A, Tozatto Maio K, Rocha V, Gehlkopf E, Milpied N, Esquirol A, Chevallier P, Blaise D et al. ( 2018 ) . Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study . Transplantation and Cellular Therapy vol. 24 , ( 11 ) 2265 - 2270 .

Avivi I, Arcaini L, Ferretti VV, Boumendil A, Finel H, Milone G, Zaja F, Liliana D et al. ( 2018 ) . High‐dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL‐GITMO . British Journal of Haematology vol. 182 , ( 6 ) 807 - 815 .

Federico M, Barrigón MDC, Marcheselli L, Tarantino V, Manni M, Sarkozy C, Alonso-Álvarez S, Wondergem M et al. ( 2018 ) . Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis . The Lancet Haematology vol. 5 , ( 8 ) e359 - e367 .

Robinson SP, Boumendil A, Finel H, Dreger P, Sureda A, Hermine O, Montoto S ( 2018 ) . High-dose therapy with BEAC conditioning compared to BEAM conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: no differences in toxicity or outcome. A matched-control study of the EBMT-Lymphoma Working Party . Bone Marrow Transplantation vol. 53 , ( 12 ) 1553 - 1559 .

Sureda A, Montoto S, Dreger P, Hamadani M, Pasquini MC ( 2018 ) . Reply to the persistent uncertainty of when to recommend allogeneic stem cell transplantation in follicular iymphoma . Cancer vol. 124 , ( 16 ) 3455 - 3456 .

Hamadani M, Ahn KW, Litovich C, Herve F, Smith SM, Fenske TS, Boumendil A, Dietrich S et al. ( 2018 ) . Post-transplant cyclophosphamide (PT-Cy) based haploidentical transplantation (haploHCT) versus matched sibling (MSD) or matched unrelated donor (MUD) reduced intensity conditioning (RIC) HCT for diffuse large b-cell lymphoma (DLBCL): A CIBMTR and EBMT analysis . Journal of Clinical Oncology . vol. 36 , 7056 - 7056 .

Dreger P, Michallet M, Bosman P, Dietrich S, Sobh M, Boumendil A, Nagler A, Scheid C et al. ( 2018 ) . Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties . Bone Marrow Transplantation vol. 54 , ( 1 ) 44 - 52 .

Mohty M, Duarte RF, Kuball J, Bader P, Basak GW, Bonini C, Carreras E, Chabannon C et al. ( 2018 ) . Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation . Bone Marrow Transplantation vol. 53 , ( 12 ) 1548 - 1552 .

Gleeson M, Peckitt C, To YM, Edwards L, Oates J, Wotherspoon A, Attygalle AD, Zerizer I et al. ( 2018 ) . CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial . The Lancet Haematology vol. 5 , ( 5 ) e190 - e200 .

Federico M, Bellei M, Marcheselli L, Schwartz M, Manni M, Tarantino V, Pileri S, Ko Y et al. ( 2018 ) . Peripheral T cell lymphoma, not otherwise specified (PTCL‐NOS). A new prognostic model developed by the International T cell Project Network . British Journal of Haematology vol. 181 , ( 6 ) 760 - 769 .

Bellei M, Foss FM, Shustov AR, Horwitz SM, Marcheselli L, Kim WS, Cabrera ME, Dlouhy I et al. ( 2018 ) . The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project . Haematologica vol. 103 , ( 7 ) 1191 - 1197 .

Erblich T, Montoto S ( 2018 ) . Treating relapsed follicular lymphoma . Expert Review of Hematology vol. 11 , ( 5 ) 403 - 410 .

Passweg JR, Baldomero H, Bader P, Basak GW, Bonini C, Duarte R, Dufour C, Kröger N et al. ( 2018 ) . Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report . Bone Marrow Transplantation vol. 53 , ( 9 ) 1139 - 1148 .

Bazarbachi A, Boumendil A, Finel H, Mohty M, Castagna L, Peggs KS, Blaise D, Afanasyev B et al. ( 2018 ) . Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party . British Journal of Haematology vol. 181 , ( 1 ) 86 - 96 .

Avivi I, Boumendil A, Finel H, Nagler A, de Sousa AB, Santasusana JMR, Vandenberghe E, Afanasyev B et al. ( 2018 ) . Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation . Bone Marrow Transplantation vol. 53 , ( 8 ) 1001 - 1009 .

Sureda A, Zhang M, Dreger P, Carreras J, Fenske T, Finel H, Schouten H, Montoto S et al. ( 2018 ) . Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR . Cancer vol. 124 , ( 8 ) 1733 - 1742 .

Araf S, Wang J, Korfi K, Pangault C, Kotsiou E, Rio-Machin A, Rahim T, Heward J et al. ( 2018 ) . Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma . Leukemia vol. 32 , ( 5 ) 1261 - 1265 .

Robinson SP, Boumendil A, Finel H, Peggs KS, Chevallier P, Sierra J, Finke J, Poiré X et al. ( 2018 ) . Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party . Bone Marrow Transplantation vol. 53 , ( 5 ) 617 - 624 .

Sureda A, Chabannon C, Masszi T, Pohlreich D, Scheid C, Thieblemont C, Wahlin BE, Sakellari I et al. ( 2018 ) . Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients with Lymphoma Receiving Plerixafor . BONE MARROW TRANSPLANTATION . vol. 53 , 599 - 600 .

Dietrich S, Sureda A, Castagna L, Milpied N, Ghesquieres H, Bazarbachi A, Houot R, Maschmeyer G et al. ( 2018 ) . Checkpoint Inhibitor Therapy for Hodgkin Lymphoma after Allogeneic Bone Marrow Transplantation: A retrospective analysis of the EBMT-Lymphoma Working Party . BONE MARROW TRANSPLANTATION . vol. 53 , 604 - 604 .

Sellner L, Dreger P, Koster L, Browne P, Beelen D, De Groot MR, Blaise D, Valkova V et al. ( 2018 ) . Early Events after Allogeneic Stem Cell Transplantation in Patients with Follicular Lymphoma Exposed to Idelalisib: A Survey of the EBMT Lymphoma Working Party . BONE MARROW TRANSPLANTATION . vol. 53 , 106 - 107 .

Hertenstein B, Beohou E, van der Werf S, Blaise D, Arnold R, Afanasyev B, Dreger P, Socie G et al. ( 2018 ) . Graft failure after reduced intensity conditioning - a retrospective study of the Transplant Complications Working Party EBMT . BONE MARROW TRANSPLANTATION . vol. 53 , 58 - 59 .

Phillips E, Burton C, Kirkwood A, Barrans S, Lawrie A, Rule S, Patmore R, Pettengell R et al. ( 2018 ) . High discrepancy rates in the diagnosis of Burkitt lymphoma: pathology and updated survival results from the UK NCRI/LLR R-CODOX-M trial . BRITISH JOURNAL OF HAEMATOLOGY . vol. 181 , 78 - 79 .

Sellner L, Koster L, Vandenberghe E, Beelen DW, de Groot MR, Blaise D, Valkova V, Passweg J et al. ( 2018 ) . Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: A survey of the EBMT lymphoma working party . ONCOLOGY RESEARCH AND TREATMENT . vol. 41 , 118 - 118 .

Styczynski J, Tridello G, Koster L, Iacobelli S, van Biezen A, van der Werf S, Mikulska M, Gil L et al. ( 2018 ) . Lethal infectious complications after hematopoietic stem cell transplantation: progress and challenges in Infectious Diseases Working Party study . BONE MARROW TRANSPLANTATION . vol. 53 , 94 - 95 .

Robinson S, Wadhera K, Boumendil A, Finel H, Khvedelidze I, Dietrich S, Dreger P, Hermine O et al. ( 2018 ) . Variation in the Use of Stem Cell Transplantation in the Management of Follicular Lymphoma (FL) and Indolent Lymphomas: a Study of the Lymphoma Working Party-EBMT . BONE MARROW TRANSPLANTATION . vol. 53 , 621 - 622 .

Shouval R, Fein J, Labopin M, Kröger N, Duarte RF, Bader P, Chiara B, Kuball J et al. ( 2017 ) . Transplantation Outcome By Disease Risk and Donor Type over Time: An Analysis of 100,000 Allogeneic Stem Cell Transplantation on Behalf of the Acute Leukemia Working Party of the EBMT . Blood . vol. 130 ,

Chabannon C, Kuball J, Mcgrath E, Bader P, Dufour C, Lankester A, Basak GW, Montoto S et al. ( 2017 ) . CAR-T cells: the narrow path between hope and bankruptcy? . Bone Marrow Transplantation vol. 52 , ( 12 ) 1588 - 1589 .

Akhtar S, Montoto S, Boumendil A, Finel H, Masszi T, Jindra P, Nemet D, Fuhrmann S et al. ( 2017 ) . High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte‐predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation‐lymphoma working party . American Journal of Hematology vol. 93 , ( 1 ) 40 - 46 .

Benekou K, Montoto S ( 2017 ) . Role of stem cell transplant in lymphoma in the era of new drugs . Current Opinion in Oncology vol. 29 , ( 6 ) 455 - 459 .

Martínez C, Gayoso J, Canals C, Finel H, Peggs K, Dominietto A, Castagna L, Afanasyev B et al. ( 2017 ) . Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation . Journal of Clinical Oncology vol. 35 , ( 30 )

Domenech ED, Boumendil A, Climent F, Socié G, Kroschinsky F, Finel H, Vandenbergue E, Nemet D et al. ( 2017 ) . ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO‐HSCT) FOR PATIENTS WITH RELAPSED/REFRACTORY SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA (R/R SALCL). A RETROSPECTIVE ANALYSIS OF THE LYMPHOMA WORKING PARTY‐EBMT . Hematological Oncology vol. 35 , ( S2 ) 242 - 243 .

Baptista M, Tapia G, Muñoz‐Marmol A, Muncunill J, Montoto S, Gribben J, Calaminici M, Martinez A et al. ( 2017 ) . APPLICATION OF CELL‐OF‐ORIGIN SUBTYPES DETERMINED BY DIGITAL GENE EXPRESSION IN HIV‐RELATED DIFFUSE LARGE B‐CELL LYMPHOMAS . Hematological Oncology vol. 35 , ( S2 ) 156 - 157 .

Bazarbachi A, Boumendil A, Finel H, Mohty M, Castagna L, Blaise D, Peggs K, Afanasyev B et al. ( 2017 ) . BRENTUXIMAB VEDOTIN FOR RELAPSED HODGKIN LYMPHOMA AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: a RETROSPECTIVE STUDY OF THE EBMT LYMPHOMA WORKING PARTY . Hematological Oncology vol. 35 , ( S2 ) 83 - 84 .

Gleeson M, Peckitt C, To YM, Edwards L, Chau I, Johnson P, Ardeshna KM, Wotherspoon A et al. ( 2017 ) . CHOP VERSUS GEM‐P IN THE FIRST‐LINE TREATMENT OF T‐CELL LYMPHOMA (PTCL): INITIAL RESULTS OF THE UK NRCI PHASE II RANDOMISED CHEMO‐T TRIAL . Hematological Oncology vol. 35 , ( S2 ) 75 - 76 .

Pettengell R, Uddin R, Boumendil A, Robinson SP, Smith G, Hawkins T, Metzner B, Caballero MD et al. ( 2017 ) . DURABLE BENEFIT OF RITUXIMAB MAINTENANCE POST‐AUTOGRAFT IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: 12‐YEAR FOLLOW‐UP OF THE EBMT LYMPHOMA WORKING PARTY LYM1 TRIAL . Hematological Oncology vol. 35 , ( S2 ) 32 - 33 .

Fox CP, Bellei M, Manni M, Kim SJ, Ko YH, Shustov AR, Cabrera ME, Chiattone CS et al. ( 2017 ) . IMPROVED SURVIVAL OUTCOMES FOR PATIENTS WITH EXTRA‐NODAL NK/T LYMPHOMA: DATA FROM 140 PATIENTS PROSPECTIVELY REGISTERED IN THE INTERNATIONAL T‐CELL PROJECT . Hematological Oncology vol. 35 , ( S2 ) 78 - 79 .

Federico M, Caballero D, Marcheselli L, Tarantino V, Sarkozy C, Guillermo AL, Wondergem M, Kimby E et al. ( 2017 ) . THE RISK OF TRANSFORMATION OF FOLLICULAR LYMPHOMA “TRANSFORMED” BY RITUXIMAB: THE ARISTOTLE STUDY PROMOTED BY THE EUROPEAN LYMPHOMA INSTITUTE . Hematological Oncology vol. 35 , ( S2 ) 115 - 116 .

Gleeson M, Peckitt C, Cunningham D, To YM, Edwards L, Chau I, Johnson P, Ardeshna KM et al. ( 2017 ) . THE ROLE OF 18F FDG‐PET/CT IN PERIPHERAL T‐CELL LYMPHOMA (PTCL): INITIAL RESULTS OF THE UK NCRI MULTICENTRE PHASE II RANDOMISED CHEMO‐T TRIAL PET/CT SUBSTUDY . Hematological Oncology vol. 35 , ( S2 ) 244 - 245 .

Kassam S, Chernucha E, O’Neill A, Hemmaway C, Cummins T, Montoto S, Lennard A, Adams G et al. ( 2017 ) . High-dose chemotherapy and autologous stem cell transplantation for primary central nervous system lymphoma: a multi-centre retrospective analysis from the United Kingdom . Bone Marrow Transplantation vol. 52 , ( 9 ) 1268 - 1272 .

Bento L, Boumendil A, Finel H, Le Gouill S, Amorim S, Monjanel H, Bouabdallah R, Bay JO et al. ( 2017 ) . Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party . Bone Marrow Transplantation vol. 52 , ( 8 ) 1120 - 1125 .

Passweg JR, Baldomero H, Bader P, Bonini C, Duarte RF, Dufour C, Gennery A, Kröger N et al. ( 2017 ) . Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report . Bone Marrow Transplant vol. 52 , ( 6 ) 811 - 817 .

Magnano L, Montoto S, González-Barca E, Briones J, Sancho JM, Muntañola A, Salar A, Besalduch J et al. ( 2017 ) . Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial . Annals of Hematology vol. 96 , ( 4 ) 639 - 646 .

Baptista MJ, Tapia G, Munoz-Marmol A-M, Muncunill J, Montoto S, Martinez A, Gonzalez-Farre B, Lopez-Guillermo A et al. ( 2017 ) . APPLICATION OF CELL-OF-ORIGIN SUBTYPES DETERMINED BY DIGITAL GENE EXPRESSION IN HIV-RELATED DIFFUSE LARGE B CELL LYMPHOMAS . HAEMATOLOGICA . vol. 102 , 572 - 572 .

Jagasia M, Beohou E, van der Werf S, Niederwieser D, Dreger P, Meijer E, Chevallier P, Sengeloev H et al. ( 2017 ) . Addition of rituximab in reduced intensity conditioning regimens for B-cell malignancies does not influence transplant outcomes: an EBMT registry analyses . BONE MARROW TRANSPLANTATION . vol. 52 , S83 - S83 .

Shouval R, Fein J, Labopin M, Kroger N, Duarte RF, Bader P, Bonini C, Dreger P et al. ( 2017 ) . Application of the disease risk index for risk stratification of allogeneic hematopoietic stem cell transplantation in a large cohort of the European Society for Blood and Marrow Transplantation (EBMT) . BONE MARROW TRANSPLANTATION . vol. 52 , S12 - S13 .

Domingo-Domenech E, Boumendil A, Climent F, Sengeloev H, Ljungman P, Wattad M, Arat M, Finel H et al. ( 2017 ) . Autologous stem cell transplantation for systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT . BONE MARROW TRANSPLANTATION . vol. 52 , S440 - S440 .

Shustov A, Bellei M, Pileri SA, Montoto S, Manni M, Horwitz SM, Cabrera ME, Chiattone C et al. ( 2017 ) . Clinical Outcomes of Patients with Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase-Positive (ALCL, ALK plus ): Data from 119 Patients Prospectively Registered in the International T-Cell Project . BLOOD . vol. 130 ,

Morales JF, Montoto SS, Fagiolino P, Ruiz ME ( 2017 ) . Current State and Future Perspectives in QSAR Models to Predict Blood- Brain Barrier Penetration in Central Nervous System Drug R&D . Mini-Reviews in Medicinal Chemistry vol. 17 , ( 3 ) 247 - 257 .

Styczynski J, Tridello G, Knelange N, Ljungman PT, Gil LA, Mikulska M, Socie G, Chevallier P et al. ( 2017 ) . Donor EBV-Positive Serostatus Increases the Risk of Chronic GVHD in Patients with Myeloid and Lymphoid Malignancies Other Than Acute Leukemia: Infectious Diseases Working Party EBMT Study . BLOOD . vol. 130 ,

Araf S, Wang J, Korfi K, Pangault C, Kotsiou E, Rio-Machin A, Rahim T, Heward JA et al. ( 2017 ) . Genomic Profiling Reveals Spatial Intra-Tumor Heterogeneity in Follicular Lymphoma . BLOOD . vol. 130 ,

Kassam S, Chernucha E, O'Neill A, Hemmaway C, Cummins T, Montoto S, Lennard A, Adams G et al. ( 2017 ) . High-dose chemotherapy and autologous stem cell transplantation for primary central nervous system lymphoma: a multi-centre retrospective analysis from the United Kingdom . BONE MARROW TRANSPLANTATION vol. 52 , ( 9 ) 1268 - 1272 .

Dreger P, Michallet M, Bosman P, Sobh M, Boumendil A, Nagler A, Scheid C, Cornelissen J et al. ( 2017 ) . Ibrutinib for bridging to allogeneic hematopoietic stem cell transplantation (alloHCT) in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) is safe and effective: Updated results of a study by the EBMT Chronic Malignancy and Lymphoma Working Parties, the French Cooperative Group for CLL, and the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC) . BONE MARROW TRANSPLANTATION . vol. 52 , S99 - S99 .

Greinix H, Beohou E, van der Werf S, Niederwieser D, Blaise D, Dreger P, Arnold R, Meijer E et al. ( 2017 ) . Impact of ATG use on the outcome of patients with hematological malignancies undergoing reduced-intensity conditioning for allogeneic hematopoietic cell transplantation . BONE MARROW TRANSPLANTATION . vol. 52 , S61 - S61 .

Robinson S, Finel H, Boumendil A, Tilly H, Salles G, Corradini P, Cairoli R, Pytlik R et al. ( 2017 ) . In the Era of Chemoimmunotherapy, Relapse Post Autologous Stem Cell Transplantation for Follicular Lymphoma Is Associated with Prolonged Overall Survival. an Analysis By the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT) . BLOOD . vol. 130 ,

Kyriakou C, Advani RH, Ansell SM, Buske C, Castillo JJ, Dreger P, Gertz MA, Giralt SA et al. ( 2017 ) . Indications for Hematopoietic Stem Cell Transplantation in Patients with Waldenstrom's Macroglobulinemia: A Consensus Project of the EBMT Lymphoma Working Party (LWP)/European Consortium for Waldenstrom's Macroglobulinemia (ECWM)/International Waldenstrom's Macroglobulinemia Foundation (IWMF) . BLOOD . vol. 130 ,

Robinson S, Boumendil A, Finel H, Thomson K, Chevallier P, Sierra J, Fincke J, Poire X et al. ( 2017 ) . Long-term follow-up of patients undergoing reduced intensity allogeneic stem cell transplantation for mantle cell lymphoma. a study of the Lymphoma Working Party-EBMT . BONE MARROW TRANSPLANTATION . vol. 52 , S92 - S93 .

Gonzalez-Barca E, Boumendil A, Blaise D, Trneny M, Masszi T, Finel H, Michieli M, Bittenbring JT et al. ( 2017 ) . Management and Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsed after Autologous Hemopoietic Stem Cell Transplantation (auto-HSCT): A Retrospective Analysis of the Lymphoma Working Party (LWP) of the European Society for Blood and Marrow Transplantation (EBMT) . BLOOD . vol. 130 ,

Dreger P, Boumendil A, Koster L, Scheid C, Passweg J, Veelken H, Cahn Y, Collin M et al. ( 2017 ) . No evidence for an increased GVHD risk associated with post-transplant Idelalisib given for relapse of chronic lymphocytic leukemia or lymphoma: First results of a survey by the EBMT chronic malignancy and lymphoma working parties . BONE MARROW TRANSPLANTATION . vol. 52 , S424 - S425 .

Paviglianiti A, Tozatto-Maio K, Rocha V, Gehlkopf E, Milpied N, Esquirol A, Chevallier P, Blaise D et al. ( 2017 ) . Outcomes of Cord Blood Transplantation for Adult Patients with Hodgkin Lymphoma, a Eurocord and EBMT Lymphoma Working Party Study . BLOOD . vol. 130 ,

Sanchez-Ortega I, Basak G, Beohou E, van der Werf S, Labopin M, Kroeger N, Montoto S, Nagler A et al. ( 2017 ) . Performance status drives the impact of age on the outcomes of autologous hematopoietic cell transplantation in elderly patients aged 65 and older: A retrospective analysis by the complications and quality of life working party of the EBMT . BONE MARROW TRANSPLANTATION . vol. 52 , S65 - S66 .

Dreger P, Koster L, Passweg JR, Collin M, Scheid C, Charbonnier A, Ciceri F, Thieblemont C et al. ( 2017 ) . Safety and Efficacy of Idelalisib Treatment of Chronic Lymphocytic Leukemia (CLL) or Lymphoma Relapsing after Allogeneic Hematopoietic Cell Transplantation (alloHCT): A Survey By the EBMT Chronic Malignancies and Lymphoma Working Parties . BLOOD . vol. 130 ,

Bazarbachi A, Boumendil A, Finel H, Mohty M, Castagna L, Peggs K, Blaise D, Afanasyev B et al. ( 2017 ) . Salvage Brentuximab Vedotin prior to allogeneic hematopoietic cell transplantation in classical Hodgkin lymphoma does not impact survival but reduces the incidence of chronic GVHD: a retrospective study of the EBMT Lymphoma Working Party . BONE MARROW TRANSPLANTATION . vol. 52 , S93 - S93 .

Schmidt-Hieber M, Tridello G, Mikulska M, Knelange N, Blaise D, Socie G, Volin L, Schaap N et al. ( 2017 ) . The Prognostic Impact of the Donor/Recipient CMV Serostatus in Patients with Different Chronic Hematological Disorders after Allogeneic Hematopoietic Stem Cell Transplantation: A Report from the Infectious Diseases Working Party of EBMT . BLOOD . vol. 130 ,

Robinson S, Boumendil A, Finel H, Sureda A, Hermine O, Dreger P, Montoto S ( 2017 ) . The outcome of BEAC conditioning regimen prior to autologous stem cell transplant in non-Hodgkin lymphoma (NHL) and comparison with BEAM conditioning: a Lymphoma Working Party-EBMT study . BONE MARROW TRANSPLANTATION . vol. 52 , S71 - S72 .

Ruutu T, van der Werf S, van Biezen A, Backman J, Nagler A, Montoto S, Mohty M, Niederwieser D et al. ( 2017 ) . Use of Busulfan in Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Adults: A Survey By the Complications and Quality of Life Working Party of the EBMT . BLOOD . vol. 130 ,

Passweg JR, Baldomero H, Bader P, Bonini C, Duarte RF, Dufour C, Gennery A, Kroeger N et al. ( 2017 ) . Use of haploidentical stem cell transplantation continues to increase, the 2015 European society for blood and marrow transplant activity survey report . BONE MARROW TRANSPLANTATION . vol. 52 , S191 - S192 .

Meissner J, Finel H, Dietrich S, Boumendil A, Kanfer E, Laboure G, Abecasis M, Cornelissen J et al. ( 2016 ) . Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience . Bone Marrow Transplantation vol. 52 , ( 4 ) 650 - 652 .

Basak GW, Sánchez-Ortega I, Beohou E, van der Werf S, Labopin M, van Biezen A, Dreger P, Montoto S et al. ( 2016 ) . Allogeneic Hematopoietic Cell Transplantation in Elderly Patients Aged 65 and Older: A Retrospective Analysis By the Complications and Quality of Life Working Party of the EBMT . Blood . vol. 128 ,

Sánchez-Ortega I, Basak GW, Beohou E, van der Werf S, Labopin M, van Biezen A, Kroeger N, Montoto S et al. ( 2016 ) . Autologous Hematopoietic Cell Transplantation in Elderly Patients Aged 65 and Older: A Retrospective Analysis By the Complications and Quality of Life Working Party of the EBMT . Blood . vol. 128 ,

Huebel K, Re A, Boumendil A, Finel H, Hentrich M, Michieli M, Kanfer E, Diez-Martin JL et al. ( 2016 ) . Autologous Stem Cell Transplantation (autoSCT) for HIV-Associated Lymphoma in the Era of Combination Antiretroviral Therapy (cART): A Retrospective Analysis of the EBMT Lymphoma Working Party . Blood . vol. 128 ,

Dreger P, Michallet M, Hoek J, Boumendil A, Sobh M, Muller L, Vandenberghe EA, Scortechini I et al. ( 2016 ) . Ibrutinib for Bridging to Allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) in Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) Is Safe and Effective: First Results of a Survey By the Chronic Malignancy and the Lymphoma Working Parties of the EBMT . Blood . vol. 128 ,

Kyriakou C, Boumendil A, Finel H, Schmitz N, Sengeloev H, Mackinnon S, Blaise D, Chevallier P et al. ( 2016 ) . Long-Term Outcome of Allogeneic Stem Cell Transplantation (allo-SCT) in Patients with Waldenstrom Macroglobulinemia (WM)-a Retrospective Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT) . Blood . vol. 128 ,

Phillips EH, Kirkwood AA, Lawrie A, Rule S, Patmore R, Pettengell R, Burton CH, Ardeshna KM et al. ( 2016 ) . Low Rates of CNS Relapse in High Risk DLBCL Patients Treated with R-CODOX-M and R-IVAC: Results from a Phase 2 UK NCRI/Bloodwise Trial . Blood . vol. 128 ,

Akhtar S, Montoto S, Boumendil A, Castagna L, Finel H, Masszi T, Jindra P, Nemet D et al. ( 2016 ) . Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): High Efficacy of High Dose Chemotherapy and Autologous Stem Cell Transplantation (HDC auto-SCT). A Study of the Lymphoma Working Party (LWP) of the European Society for Blood and Marrow Transplantation (EBMT) . Blood . vol. 128 ,

Shouval R, Fein J, Labopin M, Kroger N, Duarte RF, Bader P, Bonini C, Dreger P et al. ( 2016 ) . The Disease Risk Index Is a Robust Tool for Allogeneic Hematopoietic Stem Cell Transplantation Risk Stratification: An Independent Validation Study on a Large Cohort of the European Society for Blood and Marrow Transplantation (EBMT) . Blood . vol. 128 ,

Bellei M, Foss FM, Horwitz SM, Marcheselli L, Kim WS, Cabrera ME, Dlouhy I, Nagler A et al. ( 2016 ) . The Outcome of Patients with Primary Refractory or Relapsed Peripheral T-Cell Lymphoma: Analysis of 1020 Cases Registered in the Prospective T-Cell Project . Blood . vol. 128 ,

Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Al Seraihi AF et al. ( 2016 ) . Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma (vol 48, pg 183, 2016) . NATURE GENETICS vol. 48 , ( 6 ) 700 - 700 .

Robinson SP, Boumendil A, Finel H, Schouten H, Ehninger G, Maertens J, Crawley C, Rambaldi A et al. ( 2016 ) . Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT † . Annals of Oncology vol. 27 , ( 6 ) 1088 - 1094 .

Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Seraihi AFA et al. ( 2016 ) . Corrigendum: Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma . Nat Genet vol. 48 , ( 6 ) 700 - 700 .

Dietrich S, Finel H, Martinez C, Tischer J, Blaise D, Chevallier P, Castagna L, Milpied N et al. ( 2016 ) . Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: a registry study by the European society for blood and marrow transplantation . Leukemia

Okosun J, Montoto S, Fitzgibbon J ( 2016 ) . The routes for transformation of follicular lymphoma . Current Opinion in Hematology vol. 23 , ( 4 ) 1 - 1 .

Conconi A, Montoto S, Montserrat E, Zucca E ( 2016 ) . Reply to the letter to the editor ‘Survival in young adults diagnosed with follicular lymphoma’ by Calvo et al . Annals of Oncology vol. 27 , ( 6 )

Montoto S, Noy A, Ribera JM ( 2016 ) . Burkitt Lymphoma . HIV-associated Hematological Malignancies , Springer Nature

Hentrich M, Spina M, Montoto S ( 2016 ) . HIV-Associated Hodgkin Lymphoma . HIV-associated Hematological Malignancies , Springer Nature

Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Al Seraihi AF et al. ( 2016 ) . Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma . Nature Genetics vol. 48 , ( 2 ) 183 - 188 .

Sureda A, Zhang M-J, Dreger P, Carreras J, Fenske TS, Finel H, Schouten H, Montoto S et al. ( 2016 ) . Allogeneic Transplantation for Relapsed/Refractory (R/R) Follicular Lymphoma (Fl). A Joint Study Between the European Society for Blood and Marrow Transplantation (EBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR) . BONE MARROW TRANSPLANTATION . vol. 51 , S68 - S68 .

McMillan A, Rule S, Patmore R, Pettengell R, Burton C, Kirkwood A, Ardeshna K, Gambell J et al. ( 2016 ) . Front line therapy with R-CODOX-M & R-IVAC in poor risk diffuse large B cell lymphoma (IPI 3-5) yields a good outcome without transplantation: A phase 2 UK NCRI/Bloodwise Trial .

Phillips EH, Parisi I, Ardeshna K, Attwood C, Kyriakou C, Montoto S, Virchis A, Webster D et al. ( 2016 ) . Hepatitis B reactivation in patients receiving R-CHOP: Delayed reactivation and infrequent breakthrough on lamivudine prophylaxis .

Navarro-Bailon A, Taylor JG, Matthews J, Montoto S, Gribben JG ( 2016 ) . THE ROLE OF WATCH AND WAIT IN NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA: SINGLE CENTRE DATA FROM THE MODERN ERA . HAEMATOLOGICA . vol. 101 , 64 - 64 .

McMillan A, Rule S, Patmore R, Pettengell R, Burton C, Kirkwood A, Ardeshna K, Gambell J et al. ( 2016 ) . The addition of rituximab to CODOX-M & IVAC in first line therapy of poor risk Burkitt lymphoma (IPI 3-5) yields an excellent outcome: A phase 2 UK NCRI/Bloodwise Trial (LLR 04058) . BRITISH JOURNAL OF HAEMATOLOGY . vol. 173 , 88 - 88 .

Montoto S ( 2015 ) . Treatment of patients with transformed lymphoma . Hematology vol. 2015 , ( 1 ) 625 - 630 .

Sureda A, Zhang M-J, Dreger P, Carreras J, Fenske TS, Finel H, Schouten HC, Montoto S et al. ( 2015 ) . Allogeneic Stem Cell Transplantation for Relapsed / Refractory (R/R) Follicular Lymphoma (FL). a Joint Study Between the European Society for Blood and Marrow Transplantation (EBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR) . Blood . vol. 126 ,

Urbano-Ispizua A, Pavletic SZ, Flowers ME, Klein JP, Zhang MJ, Carreras J, Montoto S, Perales MA et al. ( 2015 ) . The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen . Biology of Blood and Marrow Transplantation vol. 21 , ( 10 ) 1746 - 1753 .

Conconi A, Lobetti-Bodoni C, Montoto S, Lopez-Guillermo A, Coutinho R, Matthews J, Franceschetti S, Bertoni F et al. ( 2015 ) . Life expectancy of young adults with follicular lymphoma . Annals of Oncology vol. 26 , ( 11 ) 2317 - 2322 .

Federico M, Bellei M, Luminari S, Horwitz SM, Montoto S, Zucca E, Pileri SA, Ko Y-H et al. ( 2015 ) . CD30+ expression in Peripheral T-cell lymphomas (PTCLs): A subset analysis from the international, prospective T-Cell Project . Journal of Clinical Oncology vol. 33 , ( 15_suppl ) 8552 - 8552 .

Alwan F, He A, Montoto S, Kassam S, Mee M, Burns F, Edwards S, Wilson A et al. ( 2015 ) . Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy . AIDS vol. 29 , ( 8 ) 903 - 910 .

Montoto S, Kyriakou C ( 2015 ) . Role of transplantation in lymphoplasmacytic lymphoma . Clinical Guide to Transplantation in Lymphoma , Wiley

Bachanova V, Burns LJ, Wang T, Carreras J, Gale RP, Wiernik PH, Ballen KK, Wirk B et al. ( 2015 ) . Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor . Bone Marrow Transplant vol. 50 , ( 2 ) 197 - 203 .

Castillo JJ, Bower M, Brühlmann J, Novak U, Furrer H, Tanaka PY, Besson C, Montoto S et al. ( 2015 ) . Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study . Cancer vol. 121 , ( 3 ) 423 - 431 .

Alwan F, He A, Montoto S, Kassam S, Mee M, Burns F, Edwards S, Wilson A et al. ( 2015 ) . Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt Lymphoma is safe when used with concurrent cART . BRITISH JOURNAL OF HAEMATOLOGY . vol. 169 , 51 - 51 .

Alwan F, Burns F, Cwynarski K, He A, Montoto S, Wilson A, Tenant-Flowers M, Marcus R et al. ( 2015 ) . Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent cART . HIV MEDICINE vol. 16 , 32 - 32 .

Federico M, Bellei M, Luminari S, Horwitz SM, Montoto S, Zucca E, Pileri SA, Ko Y-H et al. ( 2015 ) . CD30+expression in Peripheral T-cell lymphomas (PTCLs): A subset analysis from the international, prospective T-Cell Project . JOURNAL OF CLINICAL ONCOLOGY . vol. 33 ,

Dietrich S, Finel H, Martinez C, Tischer J, Blaise D, Milpied N, Bacigalupo A, Corradini P et al. ( 2015 ) . Haplotransplants versus other alternative donors for allogeneic stem cell transplantation in Non Hodgkin Lymphoma (NHL): A retrospective analysis of the EBMT Lymphoma Working Party . BONE MARROW TRANSPLANTATION . vol. 50 , S4 - S4 .

Magnano Mayer L, Montoto S, Gonzalez Barca E, Briones J, Sancho JM, Muntanola A, Salar A, Besalduch J et al. ( 2015 ) . PHASE II TRIAL OF TREATMENT WITH FLUDARABINe, CICLOFOSFAMIDE AND MITOXANTRONE IN PATIENTS WITH NON FOLLICULAR LYMPHOMA TREATED IN ADVANCED STAGE UPDATE WITH 12 YEARS OF MONITORING . HAEMATOLOGICA . vol. 100 , 161 - 162 .

Wallis E, Umaipalan A, Flanagan S, Montoto S, Orkin C ( 2015 ) . Post chemotherapy liver dysfunction and reactivation of Hepatitis B (HBV) and C (HCV) in an HIV-infected cohort . HIV MEDICINE vol. 16 , 41 - 41 .

Dietrich S, Finel H, Martinez C, Tischer J, Blaise D, Chevallier P, Castagna L, Milpled N et al. ( 2015 ) . Post-transplant cyclophosphamide reduces haplo-identical transplant related mortality in non hodgkin lymphoma yielding similar results as with sibling donors . Oncology Research and Treatment . vol. 38 , 45 - 45 .

Bento L, Boumendil A, Finel H, Chevallier P, Amorim S, Monjanel H, Blaise D, Bay J-O et al. ( 2015 ) . Radioimmunotherapy and BEAM chemotherapy versus BEAM as the conditioning regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective matched-control study of the LWP-EBMT . BONE MARROW TRANSPLANTATION . vol. 50 , S287 - S288 .

Montoto S ( 2015 ) . Stem cell mobilization and high dose therapy in lymphomas . DRUGS AND CELL THERAPIES IN HEMATOLOGY vol. 3 , ( 3 ) 187 - 191 .

Kyriakou C, Boumendil A, Finel H, Vernant J-P, Cornelissen JJ, Thieblemont C, Chevallier P, Hamladji R-M et al. ( 2014 ) . Autologous Stem Cell Transplantation (ASCT) for the Treatment of Patients with Waldenstrom’s Macroglobulinemia / Lymphoplasmacytic Lymphoma (WM/LPL). a Risk Factor Analysis By the European Society for Blood and Marrow Transplantation (EBMT) Lymphoma Working Party . Blood . vol. 124 ,

Dietrich S, Finel H, Martinez C, Tischer J, Blaise D, Chevallier P, Castagna L, Milpied N et al. ( 2014 ) . Haplotransplants Versus Other Alternative Donors for Allogeneic Stem Cell Transplantation in Non Hodgkin Lymphoma (NHL): A Retrospective Analysis of the EBMT Lymphoma Working Party . Blood . vol. 124 ,

Avivi I, Arcaini L, Ferretti V, Boumendil A, Finel H, Pascutto C, Milone G, Zaja F et al. ( 2014 ) . High Dose Therapy and Autologous Stem Cell Transplantation in Marginal Zone Lymphoma : An EBMT-FIL-Gimeto Retrospective Study . Blood . vol. 124 ,

Lechowicz MJ, Lazarus HM, Carreras J, Laport GG, Cutler CS, Wiernik PH, Hale GA, Maharaj D et al. ( 2014 ) . Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome . Bone Marrow Transplant vol. 49 , ( 11 ) 1360 - 1365 .

McMillan A, Ardeshna KM, Cwynarski K, Lyttelton M, McKay P, Montoto S ( 2014 ) . Central nervous system prophylaxis in patients with diffuse large B cell lymphoma, are we treating ourselves? A response to the recent BCSH Guideline - response to Griffin et al . Br J Haematol vol. 167 , ( 4 ) 579 - 580 .

Hamadani M, Hari PN, Zhang Y, Carreras J, Akpek G, Aljurf MD, Ayala E, Bachanova V et al. ( 2014 ) . Early Failure of Frontline Rituximab-Containing Chemo-immunotherapy in Diffuse Large B Cell Lymphoma Does Not Predict Futility of Autologous Hematopoietic Cell Transplantation . Biology of Blood and Marrow Transplantation vol. 20 , ( 11 ) 1729 - 1736 .

Hamadani M, Hari PN, Zhang Y, Carreras J, Akpek G, Aljurf MD, Ayala E, Bachanova V et al. ( 2014 ) . Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation . Biol Blood Marrow Transplant vol. 20 , ( 11 ) 1729 - 1736 .

El-Najjar I, Boumendil A, Luan JJ, Bouabdallah R, Thomson K, Mohty M, Colombat P, Biron P et al. ( 2014 ) . The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party . Ann Oncol vol. 25 , ( 11 ) 2224 - 2229 .

Aries J, Montoto S ( 2014 ) . Managing HIV and Hodgkin lymphoma in the twenty-first century . Curr Hematol Malig Rep vol. 9 , ( 3 ) 227 - 232 .

Martelli M, Ceriani L, Zucca E, Zinzani PL, Ferreri AJM, Vitolo U, Stelitano C, Brusamolino E et al. ( 2014 ) . [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study . J Clin Oncol vol. 32 , ( 17 ) 1769 - 1775 .

Hamadani M, Hari P, Zhang Y, Carreras J, Maloney DG, Smith SM, Montoto S, Saber W ( 2014 ) . Early rituximab failure (ERF) in relapsed diffuse large b-cell lymphoma (DLBCL) and prediction of futility of autologous hematopoietic cell transplantation (AHCT) . Journal of Clinical Oncology . vol. 32 , 7048 - 7048 .

Coutinho R, Pria AD, Gandhi S, Bailey K, Fields P, Cwynarski K, Wilson A, Papanastasopoulos P et al. ( 2014 ) . HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era . AIDS vol. 28 , ( 5 ) 689 - 697 .

Bower M, Palfreeman A, Alfa-Wali M, Bunker C, Burns F, Churchill D, Collins S, Cwynarski K et al. ( 2014 ) . British HIV Association guidelines for HIV-associated malignancies 2014 . HIV Med vol. 15 Suppl 2 , 1 - 92 .

El-Najjar I, Montoto S, McDowell A, Matthews J, Gribben J, Szyszko TA ( 2014 ) . The value of semiquantitative analysis in identifying diffuse bone marrow involvement in follicular lymphoma . Nucl Med Commun vol. 35 , ( 3 ) 311 - 315 .

Fenske TS, Zhang M-J, Carreras J, Ayala E, Burns LJ, Cashen A, Costa LJ, Freytes CO et al. ( 2014 ) . Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality . J Clin Oncol vol. 32 , ( 4 ) 273 - 281 .

Okosun J, Bödör C, Wang J, Araf S, Yang CY, Pan C, Boller S, Cittaro D et al. ( 2014 ) . Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma . Nature Genetics vol. 46 , ( 2 ) 176 - 181 .

Okosun J, Bödör C, Wang J, Araf S, Yang C-Y, Pan C, Boller S, Cittaro D et al. ( 2014 ) . Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma . Nat Genet vol. 46 , ( 2 ) 176 - 181 .

Zucca E, Martelli M, Zinzani PL, Ferreri AJM, Russo E, Montoto S, Lopez Guillermo A, Davies AJ et al. ( 2014 ) . PROGNOSTIC MODELS FOR PRIMARY MEDIASTINAL B-CELL LYMPHOMA DERIVED FROM 18-FDG PET/CT QUANTITATIVE PARAMETERS IN THE IELSG-26 STUDY . HAEMATOLOGICA . vol. 99 , 524 - 524 .

Robinson SP, Boumendil A, Finel H, Schouten H, Maertens J, Sureda A, Rambaldi A, Wahlin A et al. ( 2014 ) . REDUCED INTENSITY ALLOGENEIC SCT ACHIEVES LONG TERM DISEASE CONTROL IN PATIENTS WITH FOLLICULAR LYMPHOMA RELAPSING AFTER A PRIOR AUTOLOGOUS SCT AND MAY OVERCOME THE ADVERSE IMPACT OF EARLY RELAPSE POST AUTOSCT. AN EBMT LYMPHOMA WORKING PARTY ANALYSIS . BONE MARROW TRANSPLANTATION . vol. 49 , S59 - S59 .

Alwan F, He A, Montoto S, Kassam S, Mee M, Burns F, Edwards S, Wilson A et al. ( 2014 ) . THE ADDITION OF RITUXIMAB TO CODOX-M/IVAC CHEMOTHERAPY IN THE TREATMENT OF BURKITT LYMPHOMA IS SAFE AND IS ASSOCIATED WITH INCREASED EFFICACY IN THE HIV POSITIVE POPULATION . HAEMATOLOGICA . vol. 99 , 149 - 150 .

Kyriakou C, Boumendil A, Finel H, Luan JJ, Vernant JP, Cornelissen J, Thieblemont C, Chevallier P et al. ( 2014 ) . UPDATED EUROPEAN EXPERIENCE ON AUTOLOGOUS STEM CELL TRANSPLANTATION FOR WALDENSTROM'S MACROGLOBULINEMIA/LYMPHOPLASMACYTIC LYMPHOMA PATIENTS. A RETROSPECTIVE STUDY OF THE EBMT LYMPHOMA WORKING PARTY . HAEMATOLOGICA . vol. 99 , 505 - 505 .

Hahn T, McCarthy PL, Carreras J, Zhang M-J, Lazarus HM, Laport GG, Montoto S, Hari PN ( 2013 ) . Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin lymphoma . Biol Blood Marrow Transplant vol. 19 , ( 12 ) 1740 - 1744 .

Bachanova V, Brunstein C, Burns LJ, Wang T, Carreras J, Laport GG, Smith SM, Montoto S et al. ( 2013 ) . Alternative Donor Transplantation For Adults With Lymphoma: Comparison Of Umbilical Cord Blood Versus 8/8 HLA-Matched Donor (URD) Versus 7/8 URD . Blood . vol. 122 ,

Urbano-Ispizua A, Pavletic SZ, Flowers MED, Zhang M-J, Carreras J, Smith SM, Maloney DG, Montoto S et al. ( 2013 ) . Association Of Graft Vs. Host Disease (GVHD) With a Lower Relapse/Progression Rate After Allogeneic Hemopoietic Stem Cell Transplantation (HSCT) With Reduced Intentsity Conditioning In Patients With Follicular and Mantle Cell Lymphoma: A Cibmtr Analysis . Blood . vol. 122 ,

Wrench D, Rizvi H, Wilson A, O'Riain C, Clear A, Matthews J, Laszlo D, Lister TA et al. ( 2013 ) . Concurrent Follicular Lymphoma At Diagnosis Has a Negative Impact On The Outcome Of Patients With Diffuse Large B Cell Lymphoma . Blood vol. 122 , ( 21 )

Robinson SP, Boumendil A, Finel H, Montoto S, Dreger P ( 2013 ) . Reduced Intensity Allogeneic Stem Cell Transplantation For Follicular Lymphoma Relapsing After An Autologous Transplantation. An Analysis From The EBMT . Blood . vol. 122 ,

McMillan A, Ardeshna KM, Gambell J, Jack A, Kirkwood A, Laurie A, Montoto S, Paneesha S et al. ( 2013 ) . Rituximab and CODOX-M / IVAC Without Stem Cell Transplantation For Poor Risk Diffuse Large B Cell Lymphoma (IPI3-5) and Burkitts Lymphoma Is Feasible and Gives a High Response Rate: Preliminary Results Of a Phase 2 UK National Cancer Research Institute Trial . Blood vol. 122 , ( 21 )

Re A, Cattaneo C, Skert C, Balsalobre P, Michieli M, Bower M, Ferreri AJM, Hentrich M et al. ( 2013 ) . Stem cell mobilization in HIV seropositive patients with lymphoma . Haematologica vol. 98 , ( 11 ) 1762 - 1768 .

Robinson SP, Canals C, Luang JJ, Tilly H, Crawley C, Cahn JY, Pohlreich D, Le Gouill S et al. ( 2013 ) . The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT . Bone Marrow Transplant vol. 48 , ( 11 ) 1409 - 1414 .

Bödör C, Grossmann V, Popov N, Okosun J, O'Riain C, Tan K, Marzec J, Araf S et al. ( 2013 ) . EZH2 mutations are frequent and represent an early event in follicular lymphoma . Blood vol. 122 , ( 18 ) 3165 - 3168 .

McMillan A, Ardeshna KM, Cwynarski K, Lyttelton M, McKay P, Montoto S, British Committee for Standards in Haematology ( 2013 ) . Guideline on the prevention of secondary central nervous system lymphoma: British Committee for Standards in Haematology . Br J Haematol vol. 163 , ( 2 ) 168 - 181 .

Siegloch K, Schmitz N, Wu H-S, Friedrichs B, van Imhoff GW, Montoto S, Holler E, Ribera JM et al. ( 2013 ) . Hematopoietic stem cell transplantation in patients with lymphomatoid granulomatosis: a European group for blood and marrow transplantation report . Biol Blood Marrow Transplant vol. 19 , ( 10 ) 1522 - 1525 .

Kassam S, Bower M, Lee SM, de Vos J, Fields P, Gandhi S, Nelson M, Montoto S et al. ( 2013 ) . A retrospective, multi-center analysis of treatment intensification for human immunodeficiency virus-positive patients with high-risk diffuse large B-cell lymphoma . Leuk Lymphoma vol. 54 , ( 9 ) 1921 - 1927 .

Maziarz RT, Wang Z, Zhang M-J, Bolwell BJ, Chen AI, Fenske TS, Freytes CO, Gale RP et al. ( 2013 ) . Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement . Br J Haematol vol. 162 , ( 5 ) 648 - 656 .

Smith SM, Burns LJ, van Besien K, Lerademacher J, He W, Fenske TS, Suzuki R, Hsu JW et al. ( 2013 ) . Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma . J Clin Oncol vol. 31 , ( 25 ) 3100 - 3109 .

Liapis K, Clear A, Owen A, Coutinho R, Greaves P, Lee AM, Montoto S, Calaminici M et al. ( 2013 ) . The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies . Blood vol. 122 , ( 3 ) 424 - 433 .

Montoto S, Corradini P, Dreyling M, Ghielmini M, Kimby E, López-Guillermo A, Mackinnon S, Marcus RE et al. ( 2013 ) . Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party . Haematologica vol. 98 , ( 7 ) 1014 - 1021 .

Araf S, Montoto S ( 2013 ) . The use of interim (18)F-fluorodeoxyglucose PET to guide therapy in lymphoma . Future Oncol vol. 9 , ( 6 ) 807 - 815 .

Hamadani M, Saber W, Ahn KW, Carreras J, Cairo MS, Fenske TS, Gale RP, Gibson J et al. ( 2013 ) . Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma . Biol Blood Marrow Transplant vol. 19 , ( 5 ) 746 - 753 .

Montoto S, Matthews J, Greaves P, Lillington D, Anderson D, Gribben JG, Lister TA ( 2013 ) . Myeloablative chemotherapy for chemo-sensitive recurrent follicular lymphoma: potential benefit in second relapse . Haematologica vol. 98 , ( 4 ) 620 - 625 .

Ghielmini M, Vitolo U, Kimby E, Montoto S, Walewski J, Pfreundschuh M, Federico M, Hoskin P et al. ( 2013 ) . ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL) . Ann Oncol vol. 24 , ( 3 ) 561 - 576 .

Maramattom LV, Hari PN, Burns LJ, Carreras J, Arcese W, Cairo MS, Costa LJ, Fenske TS et al. ( 2013 ) . Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research . Biol Blood Marrow Transplant vol. 19 , ( 2 ) 173 - 179 .

Kassam S, Bower M, Lee SM, de Vos J, Fields P, Gandhi S, Nelson M, Montoto S et al. ( 2013 ) . A retrospective, multi-center analysis of treatment intensification for human immunodeficiency virus-positive patients with high-risk diffuse large B-cell lymphoma . LEUKEMIA & LYMPHOMA vol. 54 , ( 9 ) 1921 - 1927 .

Bento L, Anderson D, Davies J, Dark L, Gribben J, Montoto S ( 2013 ) . Capping of body surface area is not necessary for dosing of high dose chemotherapy and autologous stem cell rescue in patients with body surface area >2m2 . BONE MARROW TRANSPLANTATION . vol. 48 , S230 - S231 .

Wirk B, Burns L, Fenske T, Hu Z, Laport GG, Montoto S, Maloney DG, Saber W ( 2013 ) . Clinical Outcomes of Hematopoietic Cell Transplantation in Patients with Diffuse Large B Cell Lymphoma Transformed From Follicular Lymphoma . BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION . vol. 19 , S157 - S158 .

Coutinho R, Flook M, Pria A, Gandhi S, Bailey K, Fields P, Cwynarski K, Wilson A et al. ( 2013 ) . HIV STATUS DOES NOT INFLUENCE THE OUTCOME OF PATIENTS DIAGNOSED WITH DLBCL TREATED WITH R-CHOP IN THE HAART ERA . HAEMATOLOGICA . vol. 98 , 129 - 129 .

Martelli M, Zucca E, Zinzani P, Ferreri A, Vitolo U, Porro E, Stelitano C, Brusamolino E et al. ( 2013 ) . ROLE OF 18FDG-PET/CT IN POST-CHEMOTHERAPY EVALUATION OF PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA (PMLBCL): RESULTS OF THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG)-26 TRIAL (NCT00944567) . HAEMATOLOGICA . vol. 98 , 479 - 480 .

Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A, Shanyinde M, Cwynarski K et al. ( 2012 ) . HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era . J Clin Oncol vol. 30 , ( 33 ) 4111 - 4116 .

Böodöor C, Vera G, Kohlmann A, Tan K, Okosun J, Popov N, Araf S, Marzec J et al. ( 2012 ) . High Incidence of EZH2 Mutations with Variable Mutation Load in Follicular Lymphoma and Its Consequences for EZH2 Targeted Therapy . Blood vol. 120 , ( 21 )

Hamadani M, Saber W, Carreras J, Ahn KW, Laport GG, Montoto S, Maloney DG, Lazarus HM ( 2012 ) . Impact of Conditioning Regimen Intensity On the Outcomes of Allogeneic Hematopoietic Cell Transplantation for Refractory Grade-III Follicular (FL-III) and Diffuse Large B-Cell Lymphomas (DLBCL): A Cibmtr Analysis . BLOOD . vol. 120 ,

Castillo JJ, Furman M, Beltrán BE, Bibas M, Bower M, Chen W, Díez-Martín JL, Liu JJ et al. ( 2012 ) . Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy . Cancer vol. 118 , ( 21 ) 5270 - 5277 .

Solal-Céligny P, Bellei M, Marcheselli L, Pesce EA, Pileri S, McLaughlin P, Luminari S, Pro B et al. ( 2012 ) . Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study database . J Clin Oncol vol. 30 , ( 31 ) 3848 - 3853 .

Montoto S ( 2012 ) . Management of localized-stage follicular lymphoma: changing the paradigm? . J Clin Oncol vol. 30 , ( 27 ) 3328 - 3329 .

El-Najjar I, Barwick T, Avril N, Montoto S ( 2012 ) . The role of FDG-PET and bone marrow examination in lymphoma staging . Ann Oncol vol. 23 Suppl 10 , x89 - x91 .

Hale GA, Shrestha S, Le-Rademacher J, Burns LJ, Gibson J, Inwards DJ, Freytes CO, Bolwell BJ et al. ( 2012 ) . Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR . Biol Blood Marrow Transplant vol. 18 , ( 7 ) 1036 - 1043.e1 .

Spina M, Ribera J-M, Gabarre J, Wyen C, Montoto S, Jaeger U, Talamini R, Re A et al. ( 2012 ) . Hodgkin’s disease and HIV infection (HD-HIV): Prognostic factors in 596 patients (pts) within the group of European Cooperation on AIDS and Tumors (GECAT) . Journal of Clinical Oncology vol. 30 , ( 15_suppl ) 8058 - 8058 .

Okosun J, Warbey V, Shaw K, Montoto S, Fields P, Marcus R, Virchis A, McNamara C et al. ( 2012 ) . Interim fluoro-2-deoxy-D-glucose-PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection . AIDS vol. 26 , ( 7 ) 861 - 865 .

Greaves P, Wilson A, Matthews J, Brown DLP, Auer R, Montoto S, Lister TA, Gribben JG ( 2012 ) . Early relapse and refractory disease remain risk factors in the anthracycline and autologous transplant era for patients with relapsed/refractory classical Hodgkin lymphoma: a single centre intention-to-treat analysis . Br J Haematol vol. 157 , ( 2 ) 201 - 204 .

Dhairyawan R, Longwill S, Orkin C, Montoto S ( 2012 ) . An innovative joint approach to HIV and lymphoma care . Sex Transm Infect vol. 88 , ( 1 )

McNamara C, Davies J, Dyer M, Hoskin P, Illidge T, Lyttelton M, Marcus R, Montoto S et al. ( 2012 ) . Guidelines on the investigation and management of follicular lymphoma . British Journal of Haematology vol. 156 , ( 4 ) 446 - 467 .

McNamara C, Davies J, Dyer M, Hoskin P, Illidge T, Lyttelton M, Marcus R, Montoto S et al. ( 2012 ) . Guidelines on the investigation and management of follicular lymphoma . Br J Haematol vol. 156 , ( 4 ) 446 - 467 .

El-Najjar I, Szyszko T, Mc Dowell A, Matthews J, Gribben J, Montoto S ( 2012 ) . ASSESSMENT OF BONE MARROW INVOLVEMENT BY FDG-PET/CT IN PATIENTS WITH FOLLICULAR LYMPHOMA . HAEMATOLOGICA . vol. 97 , 664 - 664 .

El Najjar I, Szyszko T, Mc Dowell A, Matthews J, Gribben JG, Montoto S ( 2012 ) . Assessment of Bone Marrow Involvement by FDG-PET in Patients with Follicular Lymphoma . BLOOD . vol. 120 ,

Hamadani M, Saber W, Carreras J, Ahn KW, Laport GG, Montoto S, Maloney DG, Lazarus HM ( 2012 ) . Effect of Graft Source and Transplant Conditioning Regimen Intensity On the Outcomes of Allogeneic Hematopoietic Cell Transplantation for Refractory Mantle Cell Lymphoma (MCL): A Cibmtr Analysis . BLOOD . vol. 120 ,

Pileri SA, Bellei M, Vose JM, Connors JM, Foss FM, Horwitz SM, Montoto S, Polliack A et al. ( 2012 ) . Evaluation of Quality of Biomarker Data Capture by Peripheral Sites in an International, Cooperative Study: Analysis of 104 Cases From the T-Cell Project . BLOOD . vol. 120 ,

Pileri SA, Bellei M, Vose JM, Connors JM, Foss FM, Horwitz SM, Montoto S, Polliack A et al. ( 2012 ) . Evaluation of Quality of Biomarker Data Capture by Peripheral Sites in an International, Cooperative Study: Analysis of 104 Cases From the T-Cell Project . BLOOD . vol. 120 ,

Orkin C, Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A, Shanyinde M et al. ( 2012 ) . HIV Status does not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era . HIV MEDICINE vol. 13 , 5 - 5 .

Siegloch K, Schmitz N, Friedrichs B, Hamilton E, Harrison B, van Imhoff GW, Montoto S, Holler E et al. ( 2012 ) . Hematopoietic stem cell transplantation in patients with Lymphomatoid Granulomatosis (LG): A survey of the lymphoma working party of the European Group for Blood and Marrow Transplantation (EBMT) . ONKOLOGIE vol. 35 , 247 - 247 .

Spina M, Ribera J-M, Gabarre J, Wyen C, Montoto S, Jaeger U, Talamini R, Re A et al. ( 2012 ) . Hodgkin's disease and HIV infection (HD-HIV): Prognostic factors in 596 patients (pts) within the group of European Cooperation on AIDS and Tumors (GECAT) . JOURNAL OF CLINICAL ONCOLOGY . vol. 30 ,

Montoto S, Corradini P, Dreyling M, Ghielmini M, Kimby E, Lopez-Guillermo A, Mackinnon S, Marcus R et al. ( 2012 ) . INDICATIONS FOR HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL RESCUE AND FOR ALLOGENEIC TRANSPLANTATION IN PATIENTS WITH FOLLICULAR LYMPHOMA: A CONSENSUS PROJECT OF THE EBMT LYMPHOMA WORKING PARTY (LWP) . HAEMATOLOGICA . vol. 97 , 461 - 461 .

Hamadani M, Saber W, Carreras J, Ahn KW, Laport GG, Montoto S, Maloney DG, Lazarus HM ( 2012 ) . Impact of Conditioning Regimen Intensity On the Outcomes of Allogeneic Hematopoietic Cell Transplantation for Refractory Grade-III Follicular (FL-III) and Diffuse Large B-Cell Lymphomas (DLBCL): A Cibmtr Analysis . BLOOD . vol. 120 ,

Hassan S, Montoto S, Gribben J, De Vos J ( 2012 ) . LOW-DOSE ETOPOSIDE AND CYTARABINE: A PALLIATIVE TREATMENT OPTION IN PATIENTS WITH REFRACTORY/RELAPSED DIFFUSE LARGE B CELL LYMPHOMA NOT ELIGIBLE FOR INTENSIVE SALVAGE CHEMOTHERAPY . HAEMATOLOGICA . vol. 97 , 654 - 654 .

Wrench D, Matthews J, Montoto S, Gribben JG, Lister TA ( 2012 ) . Management without radiotherapy may be an acceptable approach for stage 1 follicular lymphoma . BRITISH JOURNAL OF HAEMATOLOGY . vol. 157 , 52 - 52 .

Ceriani L, Martelli M, Zinzani P, Govi S, Stelitano C, Vitolo U, Brusamolino E, Cabras G et al. ( 2012 ) . PET/CT Response Analysis in Primary Mediastinal Diffuse Large B-Cell Lymphoma (PMBL): Preliminary Results of the IELSG-26 Study . EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING . vol. 39 , S222 - S222 .

Ceriani L, Zucca E, Zinzani PL, Ferreri AJM, Vitolo U, Stelitano C, Brusamolino E, Cabras MG et al. ( 2012 ) . Role of Positron Emission Tomography (PET/CT) in Primary Mediastinal Large B Cell Lymphoma (PMLBCL): Preliminary Results of an International Phase II Trial (IELSG-26 Study) Conducted On Behalf of the International Extranodal Lymphoma Study Group (IELSG), the Fondazione Italiana Linfomi (FIL) and the UK NCRI Lymphoma Group . BLOOD . vol. 120 ,

Bellei M, Chiattone CS, Luminari S, Pesce EA, Cabrera ME, de Souza CA, Gabús R, Zoppegno L et al. ( 2012 ) . T-cell lymphomas in South america and europe . Rev Bras Hematol Hemoter vol. 34 , ( 1 ) 42 - 47 .

Kassam S, Bower M, Lee SM, Devos J, Fields P, Gandhi S, Nelson M, Montoto S et al. ( 2012 ) . TREATMENT INTENSIFICATION FOR HIV-POSITIVE PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA DOES NOT IMPROVE OUTCOME: A RETROSPECTIVE, MULTI-CENTRE STUDY . HAEMATOLOGICA . vol. 97 , 318 - 319 .

El-Najjar I, Matthews J, Wilson A, Gribben JG, Montoto S ( 2012 ) . The Clinical Course of Patients with Follicular Lymphoma in the Rituximab Era: A Paradigm Shift . BLOOD . vol. 120 ,

El-Najjar I, Boumendil A, Luan J, Thieblemont C, Blaise D, Thomson K, Mohty M, Colombat P et al. ( 2012 ) . The outcome of patients with follicular lymphoma in the rituximab era treated with autologous stem cell transplant according to the high-dose regimen received. A retrospective study of the EBMT Lymphoma Working Party . BONE MARROW TRANSPLANTATION . vol. 47 , S3 - S4 .

Okosun J, Boedoer C, Wang J, Araf S, Marzec J, Iqbal S, Matthews J, Calaminici M et al. ( 2012 ) . Whole Genome Sequencing in Sequential Biopsies Reveals the Genetic Evolution of Follicular Lymphoma to Transformed Follicular Lymphoma . BLOOD . vol. 120 ,

Hodson A, Crichton S, Montoto S, Mir N, Matutes E, Cwynarski K, Kumaran T, Ardeshna KM et al. ( 2011 ) . Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma . J Clin Oncol vol. 29 , ( 35 ) 4696 - 4701 .

Hahn T, McCarthy PL, Carreras J, Zhang M-J, Lazarus HM, Laport GG, Montoto S, Maloney DG et al. ( 2011 ) . A CIBMTR Prognostic Model for Progression-Free Survival (PFS) After Autologous Hematopoietic Cell Transplantation (AHCT) for Relapsed or Refractory Hodgkin Lymphoma (HL) . Blood vol. 118 , ( 21 )

Bacher U, Klyuchnikov E, Carreras J, Le-Rademacher J, Laport GG, Montoto S, Maloney DG, Hari P ( 2011 ) . Conditioning Intensity in Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Diffuse Large B-Cell Lymphoma (DLBCL) . Blood vol. 118 , ( 21 )

Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A, Shanyinde M, Cwynarski K et al. ( 2011 ) . HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era, . Blood vol. 118 , ( 21 )

Furman M, Balsalobre P, Beltran BE, Bibas M, Bower M, Chen W, Montoto S, Miranda RN et al. ( 2011 ) . HIV-Associated Plasmablastic Lymphoma: A Multi-Institutional Study . Blood vol. 118 , ( 21 )

El-Najjar I, Matthews J, Gribben J, Montoto S ( 2011 ) . Neither the FLIPI Nor the FLIPI2 Accurately Segregates Low- Risk From Intermediate- Risk Follicular Lymphoma Patients in Terms of Progression-Free Survival . Blood vol. 118 , ( 21 )

Lobetti-Bodoni C, Rancoita PM, Montoto S, Lopez-Guillermo A, Conconi A, Coutinho R, Matthews J, Franceschetti S et al. ( 2011 ) . The Importance of Age in Prognosis of Follicular Lymphoma: Clinical Features and Life Expectancy of Patients Younger Than 40 Years . Blood vol. 118 , ( 21 )

El-Najjar I, Boumendil A, Luan JJ, Thieblemont C, Blaise D, Thomson K, Le Gouill S, Lissandre S et al. ( 2011 ) . The Role of Total Body Irradiation (TBI) in the High-Dose Regimen of Patients with Follicular Lymphoma (FL) Treated with Autologous Stem Cell Transplant (ASCT) in the Rituximab Era. A Retrospective Study of the EBMT Lymphoma Working Party . Blood vol. 118 , ( 21 )

Castillo JJ, Beltran BE, Bibas M, Bower M, Collins JA, Cwynarski K, Diez-Martin JL, Hernandez-Ilizaliturri F et al. ( 2011 ) . Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: A multicenter study (vol 86, pg 256, 2011) . AM J HEMATOL vol. 86 , ( 8 ) 721 - 721 .

Stevens J, Waters R, Sieniawska C, Kassam S, Montoto S, Fitzgibbon J, Rohatiner A, Lister A et al. ( 2011 ) . Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies . Br J Haematol vol. 154 , ( 4 ) 448 - 456 .

Hari PN, Maloney DG, Carreras J, Zhang M, Laport GG, Montoto S, Fenske T ( 2011 ) . ALLOGENEIC TRANSPLANTATION (ALLOHCT) FOR PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) PROGRESSING AFTER AUTOLOGOUS TRANSPLANTATION (AUTOHCT). ON BEHALF OF THE WRITING COMMITTEE, CENTER FOR INTERNATIONAL BLOOD & MARROW TRANSPLANT RESEARCH (CIBMTR), MEDICAL COLLEGE OF WISCONSIN, MILWAUKEE, WI . ANNALS OF ONCOLOGY . vol. 22 , 94 - 94 .

Siegloch K, Schmitz N, Friedrichs B, Hamilton E, Van Imhoff GW, Montoto S, Luan JJ, Ribera JM et al. ( 2011 ) . HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMATOID GRANULOMATOSIS: A SURVEY OF THE LYMPHOMA WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION (EBMT) . ANNALS OF ONCOLOGY . vol. 22 , 235 - 236 .

Spina M, Ribera JM, Gabarre J, Wyen C, Montoto S, Jaeger U, Talamini R, Re A et al. ( 2011 ) . HODGKIN'S DISEASE AND HIV INFECTION (HD-HIV): PROGNOSTIC FACTORS IN 596 PATIENTS (PTS) WITHIN THE EUROPEAN GROUP FOR THE STUDY OF HIV AND TUMOURS (GECAT) . ANNALS OF ONCOLOGY . vol. 22 , 237 - 237 .

Fenske TS, Carreras J, Zhang M, Laport GG, Montoto S, Maloney DG, Hari PN, Behalf Writing Comm ( 2011 ) . OUTCOME OF PATIENTS WITH MANTLE CELL LYMPHOMA UNDERGOING AUTOLOGOUS VERSUS REDUCED-INTENSITY ALLOGENEIC TRANSPLANTATION . ANNALS OF ONCOLOGY . vol. 22 , 87 - 87 .

Martelli M, Ceriani L, Zinzani PL, Govi S, Stelitano C, Vitolo U, Brusamolino E, Cabras G et al. ( 2011 ) . PET/CT RESPONSE ANALYSIS IN PRIMARY MEDIASTINAL DIFFUSE LARGE B-CELL LYMPHOMA (PMBL): PRELIMINARY RESULTS OF THE IELSG-26 STUDY . ANNALS OF ONCOLOGY . vol. 22 , 133 - 133 .

Sureda A, Zang M, Hari P, Montoto S, Laport G, Lazarus H, Attal M, Russell NH et al. ( 2011 ) . RISK FACTOR ANALYSIS OF ALLOGENEIC HEMAPOIETIC CELL TRANSPLANTATION (HCT) FOR FOLLICULAR LYMPHOMA (FL). A RETROSPECTIVE STUDY ON BEHALF OF THE EBMT (THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION) LYMPHOMA WORKING PARTY AND THE CIBMTR (CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH) LYMPHOMA WORKING COMMITTEE . ANNALS OF ONCOLOGY . vol. 22 , 94 - 94 .

Federico M, Bellei M, Pesce EA, Zucca E, Pileri S, Montoto S, Weisenburger D, Rudiger T et al. ( 2011 ) . T-CELL PROJECT: AN INTERNATIONAL, PROSPECTIVE, OBSERVATIONAL STUDY OF PATIENTS WITH AGGRESSIVE PERIPHERAL T-CELL LYMPHOMA. ANALYSIS OF FIRST 524 PATIENTS . ANNALS OF ONCOLOGY . vol. 22 , 164 - 164 .

Montoto S, Matthews J, Anderson D, Lister A, Gribben J ( 2011 ) . THE NUMBER OF PREVIOUS TREATMENT LINES HAS NO IMPACT ON THE OUTCOME AFTER HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL RESCUE WITH BEAM FOR RELAPSED FOLLICULAR LYMPHOMA . ANNALS OF ONCOLOGY . vol. 22 , 115 - 115 .

Montoto S, Matthews J, Anderson D, Lister TA, Gribben JG ( 2011 ) . Outcome after high-dose therapy with autologous stem cell rescue with BEAM for relapsed follicular lymphoma . Journal of Clinical Oncology vol. 29 , ( 15_suppl ) e18512 - e18512 .

Montoto S, Fitzgibbon J ( 2011 ) . Transformation of indolent B-cell lymphomas . J Clin Oncol vol. 29 , ( 14 ) 1827 - 1834 .

Dhairyawan R, Longwill S, Orkin C, Montoto S ( 2011 ) . An innovative joint approach to HIV and lymphoma care . HIV MED vol. 12 , 38 - 38 .

Bödör C, O'Riain C, Wrench D, Matthews J, Iyengar S, Tayyib H, Calaminici M, Clear A et al. ( 2011 ) . EZH2 Y641 mutations in follicular lymphoma . Leukemia vol. 25 , ( 4 ) 726 - 729 .

Dreger P, Luan JJ, Boumendil A, Aurer I, Hermine O, Montoto S, Schmitz N, Schouten H et al. ( 2011 ) . How to become Principal Investigator of an LWP study? . BONE MARROW TRANSPLANTATION . vol. 46 , S58 - S58 .

Wrench D, Leighton P, Skibola CF, Conde L, Cazier J-B, Matthews J, Iqbal S, Carlotti E et al. ( 2011 ) . SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma . Blood vol. 117 , ( 11 ) 3147 - 3150 .

Castillo JJ, Beltran BE, Bibas M, Bower M, Collins JA, Cwynarski K, Diez-Martin JL, Hernandez-Ilizaliturri F et al. ( 2011 ) . Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study . Am J Hematol vol. 86 , ( 3 ) 256 - 261 .

Delgado J, Canals C, Attal M, Thomson K, Campos A, Martino R, Littlewood T, Jackson G et al. ( 2011 ) . The role of in vivo T-cell depletion on reduced-intensity conditioning allogeneic stem cell transplantation from HLA-identical siblings in patients with follicular lymphoma . Leukemia vol. 25 , ( 3 ) 551 - 555 .

Hahn T, McCarthy PLJ, Carreras J, Zhang M-J, Lazarus HM, Laport GG, Montoto S, Maloney DG et al. ( 2011 ) . A CIBMTR Prognostic Model for Progression-Free Survival (PFS) After Autologous Hematopoietic Cell Transplantation (AHCT) for Relapsed or Refractory Hodgkin Lymphoma (HL) . BLOOD . vol. 118 , 232 - 233 .

Bacher U, Klyuchnikov E, Carreras J, Le-Rademacher J, Laport GG, Montoto S, Maloney DG, Hari P ( 2011 ) . Conditioning Intensity in Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Diffuse Large B-Cell Lymphoma (DLBCL) . BLOOD . vol. 118 , 234 - 234 .

El-Najjar I, Szyszko T, Matthews J, Gribben J, Avril N, Montoto S ( 2011 ) . FDG-PET/CT staging in follicular lymphoma: effect on FLIPI score . BRITISH JOURNAL OF HAEMATOLOGY . vol. 153 , 48 - 48 .

Szyszko TA, El-Najjar I, McDowell A, Goddard I, Montoto S, Avril N ( 2011 ) . Follicular Lymphoma: can FDG PET/CT predict bone marrow involvement? . EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING . vol. 38 , S199 - S199 .

Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A, Shanyinde M, Cwynarski K et al. ( 2011 ) . HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era . BLOOD . vol. 118 , 1557 - 1557 .

Furman M, Balsalobre P, Beltran BE, Bibas M, Bower M, Chen W, Montoto S, Miranda RN et al. ( 2011 ) . HIV-Associated Plasmablastic Lymphoma: A Multi-Institutional Study . BLOOD . vol. 118 , 691 - 691 .

El-Najjar I, Matthews J, Gribben J, Montoto S ( 2011 ) . Neither the FLIPI Nor the FLIPI2 Accurately Segregates Low- Risk From Intermediate- Risk Follicular Lymphoma Patients in Terms of Progression-Free Survival . BLOOD . vol. 118 , 1144 - 1144 .

Lobetti-Bodoni C, Rancoita PMV, Montoto S, Lopez-Guillermo A, Conconi A, Coutinho R, Matthews J, Franceschetti S et al. ( 2011 ) . The Importance of Age in Prognosis of Follicular Lymphoma: Clinical Features and Life Expectancy of Patients Younger Than 40 Years . BLOOD . vol. 118 , 692 - 693 .

El-Najjar I, Boumendil A, Luan JJ, Thieblemont C, Blaise D, Thomson K, Le Gouill S, Lissandre S et al. ( 2011 ) . The Role of Total Body Irradiation (TBI) in the High-Dose Regimen of Patients with Follicular Lymphoma (FL) Treated with Autologous Stem Cell Transplant (ASCT) in the Rituximab Era. A Retrospective Study of the EBMT Lymphoma Working Party . BLOOD . vol. 118 , 234 - 235 .

Wrench D, Montoto S ( 2010 ) . Chemotherapy: maintenance rituximab for relapsed follicular lymphoma . Nat Rev Clin Oncol vol. 7 , ( 12 ) 677 - 678 .

Montoto S ( 2010 ) . CNS Lymphoma in the Immunocompromised Host . Lymphoma and Leukemia of the Nervous System , Springer Nature

Greaves P, Wilson A, Matthews J, Brown DLP, Montoto S, Gribben JG, Lister A ( 2010 ) . A Single-Centre Analysis by Intention to Treat with High Dose Chemotherapy and Autologous Stem Cell Rescue Following Second-Line Treatment In Patients with Hodgkin Lymphoma . BLOOD . vol. 116 , 989 - 990 .

Hodson A, Montoto S, Mir N, Pagliuca A, Cwynarski K, Ardeshna KM, Kumaran T, Matutes E et al. ( 2010 ) . Addition of Anti Viral Therapy to Chemotherapy Improves Overall Survival In Acute and Lymphomatous Adult T Cell Leukaemia/Lymphoma (ATLL) . BLOOD . vol. 116 , 1615 - 1616 .

Hodson A, Montoto S, Mir N, Pagliuca A, Cwynarski K, Ardeshna KM, Kumaran T, Matutes E et al. ( 2010 ) . Addition of Anti-Viral Therapy to Chemotherapy Improves Overall Survival In Acute and Lymphomatous Adult T-Cell Leukaemia/Lymphoma (ATLL) . BLOOD . vol. 116 , 1615 - 1616 .

Lechowicz MJ, Agovi M, Carreras J, Lazarus HM, Laport GG, Montoto S, Maloney DG, Hari P ( 2010 ) . Allogeneic Hematopoietic Cell Transplantation (AHCT) for Primary Cutaneous T Cell Lymphoma (CTCL) a Center for International Blood and Marrow Transplant Research (CIBMTR) Review . BLOOD . Conference: 52nd Annual Meeting of the American-Society-of-Hematology (ASH) ( Orlando, FL ) from: 04/12/2010 to: 07/12/2010 , vol. 116 , 165 - 165 .

Lechowicz MJ, Agovi M, Carreras J, Lazarus HM, Laport GG, Montoto S, Maloney DG, Hari P ( 2010 ) . Allogeneic Hematopoietic Cell Transplantation (AHCT) for Primary Cutaneous T Cell Lymphoma (CTCL): a Center for International Blood and Marrow Transplant Research (CIBMTR) Review . BLOOD . vol. 116 , 165 - 165 .

Smith S, Burns LJ, van Besien K, LeRademacher J, He WS, Laport GG, Montoto S, Maloney DG et al. ( 2010 ) . Autologous (auto) Versus Allogeneic (allo) Hematopoietic Cell Transplantation (HCT) for T NHL A CIBMTR Analysis . BLOOD . Conference: 52nd Annual Meeting of the American-Society-of-Hematology (ASH) ( Orlando, FL ) from: 04/12/2010 to: 07/12/2010 , vol. 116 , 303 - 304 .

Smith S, Burns LJ, van Besien K, LeRademacher J, He WS, Laport GG, Montoto S, Maloney DG et al. ( 2010 ) . Autologous (auto) Versus Allogeneic (allo) Hematopoietic Cell Transplantation (HCT) for T-NHL: A CIBMTR Analysis . BLOOD . vol. 116 , 303 - 304 .

Maziarz RT, Zhang MJ, Wang ZW, Laport GG, Lazarus HM, Montoto S, Hari P ( 2010 ) . CNS Remission at the Time of Autologous Stem Cell Transplantation Improves Outcome for Patients with Non-Hodgkin's Lymphoma with Pre Existing CNS Involvement a CIBMTR Analysis . BLOOD . Conference: 52nd Annual Meeting of the American-Society-of-Hematology (ASH) ( Orlando, FL ) from: 04/12/2010 to: 07/12/2010 , vol. 116 , 168 - 168 .

Maziarz RT, Zhang MJ, Wang ZW, Laport GG, Lazarus HM, Montoto S, Hari P ( 2010 ) . CNS Remission at the Time of Autologous Stem Cell Transplantation Improves Outcome for Patients with Non-Hodgkin's Lymphoma with Pre-Existing CNS Involvement: a CIBMTR Analysis . BLOOD . vol. 116 , 168 - 168 .

Spina M, Ribera JM, Gabarre J, Wyen C, Montoto S, Jaeger U, Talamini R, Re A et al. ( 2010 ) . Hodgkin's Disease and HIV Infection (HD HIV) Prognostic Factors In 596 Patients (pts) within the European Group for the Study of HIV and Tumours (GECAT) . BLOOD . vol. 116 , 1586 - 1586 .

Spina M, Ribera JM, Gabarre J, Wyen C, Montoto S, Jaeger U, Talamini R, Re A et al. ( 2010 ) . Hodgkin's Disease and HIV Infection (HD-HIV): Prognostic Factors In 596 Patients (pts) within the European Group for the Study of HIV and Tumours (GECAT) . BLOOD . vol. 116 , 1586 - 1586 .

Greaves P, Montoto S, Matthews J, Wilson A, Brown DLP, Lillington D, Gribben JG, Lister A ( 2010 ) . Prospective Use of a Triple FISH Probe to Predict sMDS/AML Following High Dose Therapy with Autologous Stem Cell Rescue for Lymphoma . BLOOD . vol. 116 , 1420 - 1420 .

Greaves P, Montoto S, Matthews J, Wilson A, Brown DLP, Lillington D, Gribben JG, Lister A ( 2010 ) . Prospective Use of a Triple FISH Probe to Predict sMDS/AML Following High Dose Therapy with Autologous Stem Cell Rescue for Lymphoma . Blood vol. 116 , ( 21 )

Wrench D, Sangaralingam A, Tayyib H, Kang MK, Riain C, Gupta M, Carlotti E, Bodor C et al. ( 2010 ) . TNERSF14 and EZH2 Mutations, Chr2p Gain and Copy Number Changes Targeting Genes Whose Proteins Interact with the Microenviroment In Transformed Follicular Lymphoma . BLOOD . Conference: 52nd Annual Meeting of the American-Society-of-Hematology (ASH) ( Orlando, FL ) from: 04/12/2010 to: 07/12/2010 , vol. 116 , 349 - 349 .

Wrench D, Sangaralingam A, Tayyib H, Kang MK, Riain C, Gupta M, Carlotti E, Bodor C et al. ( 2010 ) . TNFRSF14 and EZH2 Mutations, Chr2p Gain and Copy Number Changes Targeting Genes Whose Proteins Interact with the Microenvironment In Transformed Follicular Lymphoma . BLOOD . vol. 116 , 349 - 349 .

Gajewski JL, Carreras J, Lazarus HM, Laport GG, Montoto S, Maloney DG, Hari P ( 2010 ) . The Role of Hematopoietic Cell Transplantation (HCT) for Burkitt Lymphoma: a Report From the Center for International Blood and Marrow Transplant Research (CIBMTR) . BLOOD . vol. 116 , 990 - 991 .

El-Najjar I, Montoto S ( 2010 ) . Salvage Therapy for Aggressive B Cell Lymphoma . International Journal of Clinical Reviews

Agathocleous A, Rohatiner A, Rule S, Hunter H, Kerr JP, Neeson SM, Matthews J, Strauss S et al. ( 2010 ) . Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinaemia . Br J Haematol vol. 151 , ( 4 ) 346 - 353 .

Wrench D, Montoto S, Fitzgibbon J ( 2010 ) . Molecular signatures in the diagnosis and management of follicular lymphoma . Curr Opin Hematol vol. 17 , ( 4 ) 333 - 340 .

Gerlinger M, Rohatiner AZS, Matthews J, Davies A, Lister TA, Montoto S ( 2010 ) . Surveillance investigations after high-dose therapy with stem cell rescue for recurrent follicular lymphoma have no impact on management . HAEMATOL-HEMATOL J vol. 95 , ( 7 ) 1130 - 1135 .

Gerlinger M, Rohatiner AZS, Matthews J, Davies A, Lister TA, Montoto S ( 2010 ) . Surveillance investigations after high-dose therapy with stem cell rescue for recurrent follicular lymphoma have no impact on management . Haematologica vol. 95 , ( 7 ) 1130 - 1135 .

Wrench J, Skibola C, Matthews J, Cazier JB, Iqbal S, Carlotti E, Calaminici M, Davies A et al. ( 2010 ) . SNP RS6457327 ON CHROMOSOME 6P PREDICTS TRANSFORMATION OF FOLLICULAR LYMPHOMA . HAEMATOLOGICA . vol. 95 , 170 - 171 .

Wrench J, Skibola C, Matthews J, Cazier JB, Iqbal S, Carlotti E, Calaminici M, Davies A et al. ( 2010 ) . SNP RS6457327 ON CHROMOSOME 6P PREDICTS TRANSFORMATION OF FOLLICULAR LYMPHOMA . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 95 , 170 - 171 .

Hallam S, Montoto S ( 2010 ) . Follicular lymphoma: managing an indolent malignancy . Br J Hosp Med (Lond) vol. 71 , ( 5 ) 258 - 262 .

El-Najjar I, Montoto S, Lister TA ( 2010 ) . Fluorodeoxyglucose (FDG) positron emission tomography (PET) in Lymphoma . EJC SUPPLEMENTS . vol. 8 , 10 - 10 .

Bower M, Montoto S, Cwynarski K, Lumsden AS, Rajab R, Okosun J, Orkin C, Nelson M et al. ( 2010 ) . Non-germinal centre subtype of AIDS-related diffuse large B-cell lymphomas associated with improved survival . HIV MED vol. 11 , 13 - 13 .

Montoto S, Wilson J, Shaw K, Heath M, Wilson A, McNamara C, Orkin C, Nelson M et al. ( 2010 ) . Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma . AIDS vol. 24 , ( 6 ) 851 - 856 .

Siegloch K, Schmitz N, Friedrichs B, Hamilton E, van Imhoff GW, Montoto S, Luan J, Ribera JM et al. ( 2010 ) . Haematopoietic stem cell transplantation in patients with lymphomatoid granulomatosis: a retrospective survey of the Lymphoma Working Party of the EBMT . BONE MARROW TRANSPLANTATION . vol. 45 , S250 - S250 .

Maziarz RT, Wang Z, Zhang M-J, Laport GG, Lazarus HM, Montoto S, Hari PN ( 2010 ) . CNS Remission Predicts Survival After Autologous Hematopoietic Stem Cell Transplantation (AHCT) For Non-Hodgkin Lymphoma (NHL) With Pre-Existing CNS Involvement: A CIBMTR Analysis . Transplantation and Cellular Therapy vol. 16 , ( 2 )

Spina M, Ribera JM, Gabarre J, Wyen C, Montoto S, Jaeger U, Talamini R, Re A et al. ( 2010 ) . HODGKIN'S DISEASE AND HIV INFECTION (HD-HIV): PROGNOSTIC FACTORS IN 596 PATIENTS (PTS) WITHIN THE EUROPEAN GROUP FOR THE STUDY OF HIV AND TUMOURS (GECAT) . HAEMATOLOGICA . vol. 95 , S17 - S17 .

Avivi I, Montoto S, Canals C, Maertens J, Al-Ali H, Mufti GJ, Finke J, Schattenberg A et al. ( 2009 ) . Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation . Br J Haematol vol. 147 , ( 5 ) 719 - 728 .

Hale GA, Shrestha S, LeRademacher J, Lazarus HM, Laport GG, Montoto S, Hari PN ( 2009 ) . Alternative Donor Hematopoietic Cell Transplantation (HCT) After Reduced Intensity (RIC) or Nonmyeloablative (NST) Conditioning in Advanced Non-Hodgkin Lymphoma (NHL) . Blood vol. 114 , ( 22 )

Hale GA, Shrestha S, LeRademacher J, Lazarus HM, Laport GG, Montoto S, Hari PN ( 2009 ) . Alternative Donor Hematopoietic Cell Transplantation (HCT) After Reduced Intensity (RIC) or Nonmyeloalblative (NST) Conditioning in Advanced Non-Hodgkin Lymphoma (NHL) . BLOOD . vol. 114 , 1312 - 1313 .

Hahn T, McCarthy PL, Carreras J, Zhang MJ, Lazarus HM, Laport GG, Montoto S, Hari PN ( 2009 ) . Comparison of Prognostic Models for Autologous Hematopoietic Stem Cell Transplantation (AHCT) for Relapsed Hodgkin Lymphoma . BLOOD . vol. 114 , 499 - 500 .

Pasquini MC, Zhang MJ, Hari PN, Montoto S, Laport GG, Lazarus HM, Attal M, Russell NH et al. ( 2009 ) . Comparison of Unrelated and Sibling Donor Allogeneic Hematopoietic Cell Transplantation (HCT) for Follicular Lymphoma (FL) - From the Lymphoma Working Party, European Group for Blood and Marrow Transplantation (EBMT) and Center for International Blood and Marrow Transplant Research (CIBMTR) . BLOOD . vol. 114 , 360 - 360 .

Pasquini MC, Zhang M-J, Hari PN, Montoto S, Laport GG, Lazarus HM, Attal M, Russell NH et al. ( 2009 ) . Comparison of Unrelated and Sibling Donor Allogeneic Hematopoietic Cell Transplantation (HCT) for Follicular Lymphoma (FL) - From the Lymphoma Working Party, European Group for Blood and Marrow Transplantation (EBMT) and Center for International Blood and Marrow Transplant Research (CIBMTR) . Blood vol. 114 , ( 22 )

Trneny M, Bosly A, Bouabdallah K, Ma D, Shpilberg O, Montoto S, Sebban C, Hagberg H et al. ( 2009 ) . Independent Predictive Value of PET-CT Pre Transplant in Relapsed and Refractory Patients with CD20 Diffuse Large B-Cell Lymphoma (DLBCL) Included in the CORAL Study . BLOOD . vol. 114 , 363 - 363 .

Kassam S, Montoto S, Wilson A, Matthews J, Last K, Lister TA, Rohatiner AZS ( 2009 ) . Patterns of Outcome Following Recurrence in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Long Follow-up From a Single Centre . BLOOD . vol. 114 , 1141 - 1142 .

Kassam S, Montoto S, Wilson A, Matthews J, Last K, Lister TA, Rohatiner AZS ( 2009 ) . Patterns of Outcome Following Recurrence in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Long Follow-up From a Single Centre . Blood vol. 114 , ( 22 )

Delgado J, Canals C, Attal M, Thomson K, Campos A, Martino R, Littlewood TJ, Jackson GH et al. ( 2009 ) . The Role of In Vivo T-Cell Depletion On Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation From HLA-Identical Siblings in Patients with Follicular Lymphoma: An European Blood and Marrow Transplantation Study . BLOOD . vol. 114 , 1310 - 1310 .

Delgado J, Canals C, Attal M, Thomson K, Campos A, Martino R, Littlewood TJ, Jackson GH et al. ( 2009 ) . The Role of In Vivo T-Cell Depletion On Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation From HLA-Identical Siblings in Patients with Follicular Lymphoma: An European Blood and Marrow Transplantation Study . Blood vol. 114 , ( 22 )

Intermesoli T, Shamash J, Rohatiner A, Wilson A, Lister A, Montoto S ( 2009 ) . Low dose continuous chemotherapy (LD56): an active treatment with low toxicity for patients with recurrent/refractory lymphoma not eligible for intensive salvage therapy . Br J Haematol vol. 147 , ( 3 ) 408 - 410 .

Camós M, Cervantes F, Montoto S, HernáNdez-Boluda JC, Villamor N, Montserrat E ( 2009 ) . Acute Lymphoid Leukemia Following Polycythemia Vera . Leukemia & Lymphoma vol. 32 , ( 3-4 ) 395 - 398 .

Federico M, Bellei M, Pesce E, Zucca E, Pileri S, Montoto S, Weisenburger DD, Ruediger T et al. ( 2009 ) . T-Cell Project: an international, longitudinal, observational study of patients with aggressive peripheral T-cell lymphoma . Hematology Transfusion and Cell Therapy vol. 31 , ( suppl 2 ) 21 - 25 .

Kassam S, Montoto S ( 2009 ) . New treatment options for the management of non-Hodgkin lymphoma . memo - Magazine of European Medical Oncology vol. 2 , ( 2 ) 94 - 99 .

Montoto S, Bosch F, Estrach T, Blade J, Nomdedeu B, Nontserrat E ( 2009 ) . Pyoderma Gangrenosum Triggered by α2b-Interferon in a Patient with Chronic Granulocytic Leukemia . Leukemia & Lymphoma vol. 30 , ( 1-2 ) 199 - 202 .

Sanz L, López‐Guillermo A, Martínez C, Bosch F, Esteve J, Cobo F, Montoto S, Perales M et al. ( 2009 ) . Risk of relapse and clinico‐pathological features in 103 patients with diffuse large‐cell lymphoma in complete response after first‐line treatment . European Journal Of Haematology vol. 61 , ( 1 ) 59 - 64 .

Carlotti E, Wrench D, Matthews J, Iqbal S, Davies A, Norton A, Hart J, Lai R et al. ( 2009 ) . Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone . Blood vol. 113 , ( 15 ) 3553 - 3557 .

Wilson J, Montoto S, Shaw K, Orkin C, Johnson M, Nelson M, Bower M, Cwynarski K ( 2009 ) . Excellent immunological recovery following the intensive chemotherapy CODOX-M/IVAC, an effective therapy for HIV-associated Burkitt's lymphoma . HIV MED vol. 10 , 5 - 5 .

Gerlinger M, Matthews J, Davies A, Lister TA, Montoto S, Rohatiner AZS ( 2008 ) . Active Surveillance Strategies Have Neither Clinical or Survival Benefit Following High-Dose Chemotherapy and Progenitor Cell Rescue in Follicular Lymphoma . BLOOD . vol. 112 , 1117 - 1117 .

Gerlinger M, Matthews J, Davies A, Lister TA, Montoto S, Rohatiner AZS ( 2008 ) . Active Surveillance Strategies Have Neither Clinical or Survival Benefit Following High-Dose Chemotherapy and Progenitor Cell Rescue in Follicular Lymphoma . Blood vol. 112 , ( 11 )

Montoto S, Wilson J, Shaw K, Heath M, Wilson A, Orkin C, McNamara C, Johnson M et al. ( 2008 ) . Excellent Immune Recovery Following the Intensive Chemotherapy CODOX-M/IVAC, An Effective Therapy for HIV-Assochited Burkitt's Lymphorna (BL) . BLOOD . vol. 112 , 1235 - 1236 .

Montoto S, Wilson J, Shaw K, Heath M, Wilson A, Orkin C, McNamara C, Johnson M et al. ( 2008 ) . Excellent Immune Recovery Following the Intensive Chemotherapy CODOX-M/IVAC, An Effective Therapy for HIV-Associated Burkitt's Lymphoma (BL) . Blood vol. 112 , ( 11 )

Gerstner ER, Abrey LE, Schiff D, Ferreri AJM, Lister A, Montoto S, Tsang R, Thiel E et al. ( 2008 ) . CNS Hodgkin lymphoma . BLOOD vol. 112 , ( 5 ) 1658 - 1661 .

Vitolo U, Ferreri AJM, Montoto S ( 2008 ) . Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia . Crit Rev Oncol Hematol vol. 67 , ( 2 ) 172 - 185 .

Bower M, Collins S, Cottrill C, Cwynarski K, Montoto S, Nelson M, Nwokolo N, Powles T et al. ( 2008 ) . British HIV Association guidelines for HIV-associated malignancies 2008 . HIV Med vol. 9 , ( 6 ) 336 - 388 .

Gerstner R, Abrey LE, Schiff D, Ferreri AJM, Lister A, Montoto S, Tsang R, Thiel E et al. ( 2008 ) . CNS HODGKIN LYMPHOMA: AN INTERNATIONAL PRIMARY CNS LYMPHOMA COLLABORATIVE GROUP (IPCG) REPORT OF 18 CASES . HAEMATOLOGICA . vol. 93 , 191 - 191 .

Montoto S, Wilson J, Shaw K, Heath M, Wilson A, Orkin C, McNamara C, Bower M et al. ( 2008 ) . CODOX-M/IVAC CHEMOTHERAPY IS AN EFFECTIVE THERAPY FOR HIV-ASSOCIATED BURKITT'S LYMPHOMA (BL) . HAEMATOLOGICA . vol. 93 , 393 - 393 .

Gerstner R, Abrey LE, Schiff D, Ferreri AJM, Lister A, Montoto S, Tsang R, Thiel E et al. ( 2008 ) . CNS HODGKIN LYMPHOMA: AN INTERNATIONAL PRIMARY CNS LYMPHOMA COLLABORATIVE GROUP (IPCG) REPORT OF 18 CASES . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 93 , 191 - 191 .

Montoto S, Wilson J, Shaw K, Heath M, Wilson A, Orkin C, McNamara C, Bower M et al. ( 2008 ) . CODOX-M/IVAC CHEMOTHERAPY IS AN EFFECTIVE THERAPY FOR HIV-ASSOCIATED BURKITT'S ILYMPHOMA (BL) . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 93 , 393 - 393 .

Kassam S, Montoto S ( 2008 ) . Emerging drugs in B-cell non-Hodgkin's lymphoma . EXPERT OPIN EMERG DR vol. 13 , ( 2 ) 323 - 343 .

Vitolo U, Ferreri AJM, Montoto S ( 2008 ) . Follicular lymphomas . CRIT REV ONCOL HEMAT vol. 66 , ( 3 ) 248 - 261 .

Intermesoli T, Wilson A, Rohatiner A, Lister A, Montoto S ( 2008 ) . LOW DOSE CONTINUOUS CHEMOTHERAPY (LD56): AN ACTIVE TREATMENT WITH LOW TOXICITY FOR RELAPSE/REFRACTORY LYMPHOMA . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 93 , 318 - 318 .

Kassam S, Montoto S ( 2008 ) . Oncologic, endocrine & metabolic emerging drugs in B-cell non-Hodgkin's lymphoma . Expert Opin Emerg Drugs vol. 13 , ( 2 ) 323 - 343 .

Sureda A, Avivi I, Canals C, Maertens J, Niederwieser D, Mufti GJ, Finke J, Schattenberg A et al. ( 2008 ) . Impact of the intensity of conditioning regimen in 144 patients with follicular lymphoma (FL) receiving a matched unrelated donor stem cell transplant (MUD-SCT): An analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (LWP-EBMT) . Journal of Clinical Oncology vol. 26 , ( 15_suppl ) 7036 - 7036 .

Doolittle ND, Abrey LE, Shenkier TN, Tali S, Bromberg JEC, Neuwelt EA, Soussain C, Jahnke K et al. ( 2008 ) . Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report . Blood vol. 111 , ( 3 ) 1085 - 1093 .

Montoto S, Moreno C, Domingo-Domenech E, Estany C, Oriol A, Altes A, Besalduch J, Pedro C et al. ( 2008 ) . High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma . HAEMATOL-HEMATOL J vol. 93 , ( 2 ) 207 - 214 .

Bower M, Powles T, Williams S, Davis TN, Atkins M, Montoto S, Orkin C, Webb A et al. ( 2007 ) . Brief communication: rituximab in HIV-associated multicentric Castleman disease . Ann Intern Med vol. 147 , ( 12 ) 836 - 839 .

Powles T, Stebbing J, Montoto S, Nelson M, Gazzard B, Orkin C, Webb A, Bower M ( 2007 ) . Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease . BLOOD vol. 110 , ( 12 ) 4132 - 4133 .

Agathocleous A, Rule S, Johnson P, Radford JA, Lafon N, Hunter H, Kerr JP, Neeson SM et al. ( 2007 ) . Preliminary Results of a Phase I/II Study of Weekly or Twice Weekly Bortezomib in Combination with Rituximab, in Patients with Follicular Lymphoma, Mantle Cell Lymphoma and Waldenström's Macroglobulinaemia . Blood vol. 110 , ( 11 )

Agathocleous A, Rule S, Johnson P, Radford JA, Lafon N, Hunter H, Kerr JP, Neeson SM et al. ( 2007 ) . Preliminary results of a phase I/II study of weekly or twice weekly bortezomib in combination with rituximab, in patients with follicular lymphoma, mantle cell lymphoma and Waldenstrom's macroglobulinaemia . BLOOD . vol. 110 , 754A - 754A .

Montoto S, Canals C, Rohatiner AZS, Taghipour G, Sureda A, Schmitz N, Gisselbrecht C, Fouillard L et al. ( 2007 ) . Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study . Leukemia vol. 21 , ( 11 ) 2324 - 2331 .

Gerstner E, Abrey L, Schiff D, Ferreri A, Lister A, Montoto S, Tsang R, Thiel E et al. ( 2007 ) . CNS Hodgkin's lymphoma: An international primary CNS lymphoma collaborative group (IPCG) report of 13 cases . NEURO-ONCOLOGY . vol. 9 , 478 - 478 .

Bower M, Powles T, Williams S, Newsom-Davis T, Atkins M, Stebbing J, Montoto S, Nelson M et al. ( 2007 ) . Rituximab induces long-term remissions in patients with HIV-associated multicentric Castleman's disease . Journal of Clinical Oncology vol. 25 , ( 18_suppl ) 8049 - 8049 .

Montoto S, Davies AJ, Matthews J, Calaminici M, Norton AJ, Amess J, Vinnicombe S, Waters R et al. ( 2007 ) . Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma . J Clin Oncol vol. 25 , ( 17 ) 2426 - 2433 .

Montoto S ( 2007 ) . CD34+cell mobilisation with intermediate-dose cytarabine (Ara-C) in patients with lymphoma: An effective but toxic regimen . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 92 , 189 - 189 .

Mercadal S, Marcadal S, Martinez-Pozo A, Bosch F, Gine E, Muntanola A, Montoto S, Colomo L et al. ( 2007 ) . Primary extranodal follicular lymphoma: Clinicobiological features and outcome . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 92 , 263 - 263 .

Rosiñol L, Cibeira MT, Montoto S, Rozman M, Esteve J, Filella X, Bladé J ( 2007 ) . Monoclonal gammopathy of undetermined significance: predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size . Mayo Clin Proc vol. 82 , ( 4 ) 428 - 434 .

Bower M, Powles T, Williams S, Newsom-Davis T, Atkins M, Stebbing J, Montoto S, Nelson M et al. ( 2007 ) . Rituximab induces long-term remissions in patients with HIV-associated multicentric Castleman's disease . JOURNAL OF CLINICAL ONCOLOGY . vol. 25 ,

Rohatiner AZ, Davies A, Montoto S, Lister TA ( 2006 ) . Follicular Lymphoma . The Lymphomas ,

Doolittle ND, Abrey L, Shenkier T, Siegal T, Bromberg J, Neuwelt E, Soussain C, Johnston P et al. ( 2006 ) . Isolated brain parenchyma relapse of non-hodgkin's lymphoma (NHL): A descriptive analysis from the international primary CNS lymphoma collaborative group (IPCG) . BLOOD . vol. 108 , 574A - 574A .

Mercadal S, Martinez-Pozo A, Bosch F, Gine E, Muntanola A, Salamero O, Gutierrez G, Montoto S et al. ( 2006 ) . Primary extranodal follicular lymphoma: Clinicobiological features and outcome . BLOOD . vol. 108 , 695A - 696A .

Giné E, Montoto S, Bosch F, Arenillas L, Mercadal S, Villamor N, Martínez A, Colomo L et al. ( 2006 ) . The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma . Ann Oncol vol. 17 , ( 10 ) 1539 - 1545 .

Montoto S, Rohatiner AZ, Canals C, Gisselbrecht C, Fouillard L, Milpied N, Haioun C, Taghipour G et al. ( 2006 ) . Long-term follow-up of high-dose treatment (HDT) with autologous haematopoietic progenitor cell support in 702 patients (pts.) with follicular lymphoma (FL). An EBMT registry study . Journal of Clinical Oncology vol. 24 , ( 18_suppl ) 7526 - 7526 .

Montoto S, Rohatiner AZ, Canals C, Gisselbrecht C, Fouillard L, Milpied N, Haioun C, Taghipour G et al. ( 2006 ) . Long-term follow-up of high-dose treatment (HOT) with autologous haematopoietic progenitor cell support in 702 patients (pts.) with follicular lymphoma (FL). An EBMT registry study . JOURNAL OF CLINICAL ONCOLOGY . vol. 24 , 428S - 428S .

Rohatiner AZ, Davies A, Montoto S, Lister TA ( 2006 ) . Chapter 19 Follicular Lymphoma . The Lymphomas , Elsevier

Plancarte F, López-Guillermo A, Arenillas L, Montoto S, Giné E, Muntañola A, Ferrer A, Villamor N et al. ( 2006 ) . Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients . Eur J Haematol vol. 76 , ( 1 ) 58 - 63 .

Rosinol L, Blade J, Cibeira MT, Montoto S, Esteve J, Rozman M, Fililla X, Montserrat E ( 2005 ) . Monoclonal gammopathy of undetermined significance (MGUS): Predictors of outcome and recognition of an evolving type . BLOOD . vol. 106 , 345B - 345B .

Montoto S, Davies AJ, Matthews J, Calaminici M, Norton AJ, Amess J, Vinnicombe S, Rohatiner AZS et al. ( 2005 ) . Risk and Clinical Implications of Transformation of Follicular Lymphoma (FL) to Diffuse Large Cell B-Cell Lymphoma (tFL) . Blood vol. 106 , ( 11 )

Montoto S, Davies AJ, Matthews J, Calaminici M, Norton AJ, Amess J, Vinnicombe S, Rohatiner AZS et al. ( 2005 ) . Risk and clinical implications of transformation of follicular lymphoma (FL) to diffuse large cell B-cell lymphoma (tFL) . BLOOD . vol. 106 , 179A - 179A .

Perea G, Altés A, Montoto S, López-Guillermo A, Domingo-Doménech E, Fernández-Sevilla A, Ribera JM, Grau J et al. ( 2005 ) . Prognostic indexes in follicular lymphoma: a comparison of different prognostic systems . Ann Oncol vol. 16 , ( 9 ) 1508 - 1513 .

Montoto S, Lister TA ( 2005 ) . Secondary central nervous system lymphoma: risk factors and prophylaxis . Hematol Oncol Clin North Am vol. 19 , ( 4 ) 751 - viii .

Gine E, Lopez-Guillermo A, Montoto S, Bosch F, Villamor N, Muntanola A, Arenillas L, Colomo L et al. ( 2005 ) . Flipi and histological subtype are the most important predicting factors of histological transformation (HT) in follicular lymphoma (FL) . ANNALS OF ONCOLOGY . vol. 16 , 106 - 106 .

Montoto S, Lopez-Guillermo A, Domingo-Domenech E, Ribera J, Estany C, Altes A, Besalduch J, Pedro C et al. ( 2005 ) . High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone (FCM) in previously untreated patients with advance stage follicular lymphoma (FL) . ANNALS OF ONCOLOGY . vol. 16 , 152 - 153 .

Davies AJ, Apostolidis J, Micallef IN, Montoto S, Matthews J, Lister TA, Rohatiner AZS ( 2005 ) . Long-term follow up of patients with follicular lymphoma (FL) receiving high dose therapy (HDT) with autologous haematopoietic progenitor cell support at St. Bartholomew’s Hospital (SBH) . Journal of Clinical Oncology vol. 23 , ( 16_suppl ) 6568 - 6568 .

Davies AJ, Apostolidis J, Micallef IN, Montoto S, Matthews J, Lister TA, Rohatiner AZS ( 2005 ) . Long-term follow up of patients with follicular lymphoma (FL) receiving high dose therapy (HOT) with autologous haematopoietic progenitor cell support at St. Bartholomew's Hospital (SBH) . JOURNAL OF CLINICAL ONCOLOGY . vol. 23 , 577S - 577S .

Moreno C, Lopez-Guillermo A, Montoto S, Domingo-Domenech E, Ribera J, Altes A, Estany C, Besalduch J et al. ( 2005 ) . Molecular assessment by bcl-2/JH quantitative PCR technique of patients (pts) with follicular lymphoma (FL) in advanced stage treated with FCM (fludarabine, cyclophosphamide and mitoxantrone) . ANNALS OF ONCOLOGY . vol. 16 , 109 - 109 .

López-Guillermo A, Colomo L, Jiménez M, Bosch F, Villamor N, Arenillas L, Muntañola A, Montoto S et al. ( 2005 ) . Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin . J Clin Oncol vol. 23 , ( 12 ) 2797 - 2804 .

Rosiñol L, Montoto S, Cibeira MT, Bladé J ( 2005 ) . Bortezomib-induced severe hepatitis in multiple myeloma: a case report . Arch Intern Med vol. 165 , ( 4 ) 464 - 465 .

Rosinol L, Montoto S, Blade J, Cibeira MT, Rozman M, Nadal E, Gine E, Aymerich M et al. ( 2004 ) . Monoclonal gammopathy of undertermined significance (MGUS): Clinical predictors of malignant transformation in 434 patients with a long follow-up from a single institution . BLOOD . vol. 104 , 292B - 292B .

Montoto S, López-Guillermo A, Altés A, Perea G, Ferrer A, Camós M, Villela L, Bosch F et al. ( 2004 ) . Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression . Ann Oncol vol. 15 , ( 10 ) 1484 - 1489 .

Lopez-Guillermo A, Colomo L, Jimenez M, Bosch F, Villamor N, Muntanola A, Montoto S, Colomer D et al. ( 2003 ) . Diffuse large B-cell lymphoma (DLBCL): Clinico-pathologic features and outcome-according to the nodal or extranodal primary origin . BLOOD . vol. 102 , 629A - 629A .

Montoto S, Lopez-Guillermo A, Domingo-Domenech E, Ribera JM, Altes A, Estany C, Besalduch J, Escoda L et al. ( 2003 ) . High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone (FCM) in previously untreated patients with advanced stage follicular lymphoma (FL) . BLOOD . vol. 102 , 401A - 401A .

Rosiñol L, Bladé J, Esteve J, Aymerich M, Rozman M, Montoto S, Giné E, Nadal E et al. ( 2003 ) . Smoldering multiple myeloma: natural history and recognition of an evolving type . Br J Haematol vol. 123 , ( 4 ) 631 - 636 .

Perea G, Altes A, Montoto S, Lopez-Guillermo A, Bosch F, Jimenez M, Esteve J, Domingo E et al. ( 2003 ) . International and Italian prognostic indices in follicular lymphoma . HAEMATOLOGICA vol. 88 , ( 6 ) 700 - 704 .

Bladé J, Montoto S, Rosiñol L, Montserrat E ( 2003 ) . Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia? . Semin Oncol vol. 30 , ( 2 ) 329 - 331 .

Montoto S, Rozman M, Rosiñol L, Nadal E, Giné E, Aymerich M, Ferrer A, Esteve J et al. ( 2003 ) . Malignant transformation in IgM monoclonal gammopathy of undetermined significance . Semin Oncol vol. 30 , ( 2 ) 178 - 181 .

Montoto S, López-Guillermo A, Colomer D, Esteve J, Bosch F, Ferrer A, Villamor N, Moreno C et al. ( 2003 ) . Incidence and clinical significance of bcl-2/IgH rearrangements in follicular lymphoma . Leuk Lymphoma vol. 44 , ( 1 ) 71 - 76 .

Rosinol L, Blade J, Esteve J, Aymerich M, Rozman M, Montoto S, Gine E, Nadal E et al. ( 2002 ) . Smoldering multiple myeloma: Natural history and recognition of an evolving type . BLOOD . vol. 100 , 367B - 368B .

Montoto S, Blade J, Montserrat E ( 2002 ) . Monoclonal gammopathy of undetermined significance . NEW ENGL J MED vol. 346 , ( 26 ) 2087 - 2088 .

Bladé J, Filella X, Montoto S, Bosch F, Rosiñol L, Coca F, Giné E, Nadal E et al. ( 2002 ) . Interleukin 6 and tumour necrosis factor alpha serum levels in monoclonal gammopathy of undetermined significance . Br J Haematol vol. 117 , ( 2 ) 387 - 389 .

Montoto S, López-Guillermo A, Ferrer A, Camós M, Alvarez-Larrán A, Bosch F, Bladé J, Cervantes F et al. ( 2002 ) . Survival after progression in patients with follicular lymphoma: analysis of prognostic factors . Ann Oncol vol. 13 , ( 4 ) 523 - 530 .

Cervantes F, Villamor N, Esteve J, Montoto S, Rives S, Rozman C, Montserrat E ( 2001 ) . ‘Lymphoid’ blast crisis of chronic myeloid leukaemia is associated with distinct clinicohaematological features . British Journal of Haematology vol. 100 , ( 1 ) 129 - 134 .

Blade J, Esteve J, Rosinol L, Perales M, Montoto S, Tuset M, Montserrat E ( 2001 ) . Thalidomide in refractory and relapsing multiple myeloma . SEMIN ONCOL vol. 28 , ( 6 ) 588 - 592 .

García-Sanz R, Montoto S, Torrequebrada A, de Coca AG, Petit J, Sureda A, Rodríguez-García JA, Massó P et al. ( 2001 ) . Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases . Br J Haematol vol. 115 , ( 3 ) 575 - 582 .

Esteve J, Villamor N, Colomer D, Rovira M, Bosch F, Cervantes F, Lopez-Guillermo A, Blade J et al. ( 2001 ) . Different significance of minimal residual disease (MRD) after autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia (CLL): Prognostic and therapeutic implications . BLOOD vol. 98 , ( 11 ) 763A - 763A .

Ferrer A, López-Guillermo A, Montoto S, Estrach T, Colomo L, Montserrat E ( 2001 ) . Successful treatment of isolated cutaneous relapse of follicular lymphoma with rituximab . Ann Hematol vol. 80 , ( 8 ) 479 - 481 .

Blade J, Perales M, Rosinol L, Tuset M, Montoto S, Esteve O, Cobo F, Villela L et al. ( 2001 ) . Thalidomide in multiple myeloma: lack of response of soft-tissue plasmacytomas . BRIT J HAEMATOL vol. 113 , ( 2 ) 422 - 424 .

Villela L, López-Guillermo A, Montoto S, Rives S, Bosch F, Perales M, Ferrer A, Esteve J et al. ( 2001 ) . Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens . Cancer vol. 91 , ( 8 ) 1557 - 1562 .

Montoto S, Camós M, López‐Guillermo A, Bosch F, Cervantes F, Bladé J, Esteve J, Cobo F et al. ( 2000 ) . Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C‐MOPP/ABV) as first‐line treatment for patients with advanced hodgkin disease . Cancer . vol. 88 , 2142 - 2148 .

Lopez-Guillermo A, Camos M, Martino R, Ribera JM, Pedro C, Escoda T, Estany C, Altes A et al. ( 2000 ) . High-dose-CHOP plus ESHAP followed by autologous stem-cell transplantation (ASCT) for high-risk aggressive lymphomas . BLOOD vol. 96 , ( 11 ) 241B - 241B .

Montoto S, Lopez-Guillermo A, Ferrer A, Camos M, Alvarez-Larran A, Bosch F, Blade J, Cervantes F et al. ( 2000 ) . Survival from progression (SFP) in follicular lymphoma (FL): Analysis of prognostic factors in a series of 90 patients . BLOOD vol. 96 , ( 11 ) 135A - 135A .

Alvarez A, Rives S, Montoto S, Sanz C, Pereira A ( 2000 ) . Relative sensitivity of direct antiglobulin test, antibody's elution and flow cytometry in the serologic diagnosis of immune hemolytic transfusion reactions . Haematologica vol. 85 , ( 2 ) 186 - 188 .

Rives S, Carreras E, Rovira M, Montoto S, Urbano-Ispizua A, Martínez C, Perales M, Alvarez A et al. ( 1999 ) . The autologous transplantation of hematopoietic precursors on an outpatient basis: an analysis of its feasibility at the Hospital Clínic de Barcelona . Medicina Clínica vol. 113 , ( 6 ) 201 - 204 .

Ferrer A, López-Guillermo A, Bosch F, Montoto S, Hernández-Boluda JC, Camós M, Miquel R, Campo E et al. ( 1999 ) . Non-gastric mucosa-associated lymphoid tissue (MALT) lymphomas: analysis of 14 patients . Medicina Clínica vol. 112 , ( 15 ) 577 - 580 .

Filella X, Bladé J, Montoto S, Molina R, Coca F, Montserrat E, Ballesta AM ( 1998 ) . IMPAIRED PRODUCTION OF INTERLEUKIN 6 AND TUMOUR NECROSIS FACTOR α IN WHOLE BLOOD CELL CULTURES OF PATIENTS WITH MULTIPLE MYELOMA . Cytokine vol. 10 , ( 12 ) 993 - 996 .

Bladé J, Fernández-Llama P, Bosch F, Montolíu J, Lens XM, Montoto S, Cases A, Darnell A et al. ( 1998 ) . Renal Failure in Multiple Myeloma: Presenting Features and Predictors of Outcome in 94 Patients From a Single Institution . JAMA Internal Medicine vol. 158 , ( 17 ) 1889 - 1893 .

Bladé J, Filella X, Montoto S, Bosch F, Molina R, Coca F, López-Guillermo AL, Cid J et al. ( 1998 ) . Clinical relevance of interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α) serum levels in monoclonal gammopathy of undetermined significance (MGUS) . BRITISH JOURNAL OF HAEMATOLOGY . vol. 102 , 9 - 9 .